background	background	NN	B-NP
glucocorticoid	glucocorticoid	NN	I-NP
influence	influence	VBP	0
a	a	DT	0
wide	wide	JJ	0
cellular	cellular	JJ	B-NP
function	function	NN	I-NP
spectrum	spectrum	NN	I-NP
through	through	IN	0
their	their	PRP$	0
action	action	NN	0
on	on	IN	0
soluble	soluble	JJ	0
intracellular	intracellular	JJ	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
In	In	IN	0
most	most	JJS	0
cells	cells	NNS	0
,	,	,	0
unliganded	unliganded	NN	B-NP
glucocorticoid	glucocorticoid	NN	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
GR	GR	NNP	B-NP
)	)	-RRB-	0
reside	reside	JJ	0
predominately	predominately	NN	0
in	in	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
,	,	,	0
where	where	WRB	0
they	they	PRP	0
exist	exist	VBP	0
as	as	IN	0
a	a	DT	0
heteromeric	heteromeric	JJ	B-NP
complex	complex	JJ	I-NP
comprised	comprised	JJ	I-NP
minimally	minimally	NN	0
of	of	IN	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
90-kDa	90-kDa	NNP	0
and	and	CC	0
70-kDa	70-kDa	CD	0
heat	heat	NN	0
shock	shock	NN	0
proteins	proteins	NNS	0
(	(	-LRB-	0
hsp90	hsp90	NNP	B-NP
and	and	CC	0
hsp70	hsp70	CD	B-NP
)	)	-RRB-	0
.	.	.	0
Other	Other	JJ	0
proteins	proteins	NNS	0
(	(	-LRB-	0
i.e.	i.e.	FW	0
p60	p60	NN	B-NP
/	/	FW	0
Hop	Hop	NNP	0
,	,	,	0
p23	p23	NNP	B-NP
,	,	,	0
hsp40	hsp40	NNP	B-NP
,	,	,	0
FKBP52	FKBP52	NNP	B-NP
,	,	,	0
and	and	CC	0
FKBP51	FKBP51	CD	B-NP
)	)	-RRB-	0
have	have	VBP	0
been	been	VBN	0
implicated	implicated	VBN	0
in	in	IN	0
the	the	DT	0
gr-hsp90-hsp70-complex	gr-hsp90-hsp70-complex	NN	B-NP
assembly/stabilization	assembly/stabilization	NN	I-NP
in	in	IN	0
a	a	DT	0
form	form	NN	0
that	that	WDT	0
has	has	VBZ	0
high	high	JJ	0
agonist	agonist	NNS	B-NP
affinity	affinity	NN	I-NP
[	[	-LRB-	0
for	for	IN	0
review	review	NN	0
,	,	,	0
see	see	VB	0
Ref.	Ref.	CD	B-NP
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
Upon	Upon	IN	0
agonist	agonist	JJ	B-NP
binding	binding	NN	I-NP
,	,	,	0
the	the	DT	0
complex	complex	JJ	0
undergo	undergo	NN	B-NP
a	a	DT	0
transformation	transformation	NN	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
ligand	ligand	NN	B-NP
bound	bound	VBN	0
gr	gr	NN	B-NP
translocate	translocate	NN	I-NP
into	into	IN	0
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
in	in	IN	0
a	a	DT	0
manner	manner	NN	0
that	that	WDT	0
is	is	VBZ	0
determined	determined	VBN	0
by	by	IN	0
a	a	DT	0
nuclear	nuclear	JJ	B-NP
localization	localization	JJ	I-NP
sequence	sequence	NN	I-NP
(	(	-LRB-	0
nuclear	nuclear	JJ	B-NP
localization	localization	NN	I-NP
signal	signal	NN	I-NP
)	)	-RRB-	0
contained	contained	VBD	0
in	in	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
There	There	RB	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
acts	acts	VBZ	0
as	as	IN	0
a	a	DT	0
ligand-activated	ligand-activated	JJ	B-NP
transcriptional	transcriptional	JJ	I-NP
stimulator	stimulator	NN	I-NP
or	or	CC	0
primary	primary	JJ	B-NP
response	response	NN	I-NP
gene	gene	NN	I-NP
repressor	repressor	NN	I-NP
by	by	IN	0
binding	binding	VBG	0
to	to	TO	0
glucocorticoid	glucocorticoid	VB	B-NP
hormone-responsive	hormone-responsive	JJ	I-NP
element	element	NN	I-NP
(	(	-LRB-	0
GRE	GRE	NNP	B-NP
)	)	-RRB-	0
contained	contained	VBD	0
in	in	IN	0
the	the	DT	0
steroid-responsive	steroid-responsive	JJ	B-NP
gene	gene	NN	I-NP
promoter	promoter	NN	I-NP
region	region	NN	I-NP
and	and	CC	0
either	either	DT	0
facilitating	facilitating	NN	0
or	or	CC	0
repressing	repressing	VBG	0
the	the	DT	0
formation	formation	NN	0
of	of	IN	0
an	an	DT	0
active	active	JJ	0
transcriptional	transcriptional	JJ	B-NP
complex	complex	NN	I-NP
.	.	.	0
Although	Although	IN	0
little	little	RB	0
is	is	VBZ	0
known	known	VBN	0
about	about	IN	0
the	the	DT	0
molecular	molecular	JJ	B-NP
machinery	machinery	NN	I-NP
that	that	WDT	0
regulates	regulates	VBZ	0
steroid	steroid	JJ	B-NP
receptor	receptor	NN	I-NP
movement	movement	NN	I-NP
through	through	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
and	and	CC	0
into	into	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
several	several	JJ	0
studies	studies	NNS	0
suggest	suggest	VBP	0
that	that	DT	0
movement	movement	NN	0
is	is	VBZ	0
influenced	influenced	VBN	0
by	by	IN	0
reversible	reversible	JJ	0
phosphorylation	phosphorylation	NN	B-NP
.	.	.	0
Evidence	Evidence	NN	0
for	for	IN	0
this	this	DT	0
originated	originated	NN	0
from	from	IN	0
the	the	DT	0
studies	studies	NNS	0
of	of	IN	0
Qi	Qi	NNP	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
5	5	CD	0
,	,	,	0
6	6	CD	0
]	]	-RRB-	0
,	,	,	0
which	which	WDT	0
revealed	revealed	VBD	0
that	that	IN	0
the	the	DT	0
hormone	hormone	NN	B-NP
insensitivity	insensitivity	VBZ	I-NP
produced	produced	VBN	0
by	by	IN	0
cellular	cellular	JJ	B-NP
transformation	transformation	NN	I-NP
with	with	IN	0
v-mo	v-mo	NN	B-NP
(	(	-LRB-	0
a	a	FW	0
serine	serine	NN	B-NP
/	/	NN	I-NP
threonine	threonine	NN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
that	that	IN	0
acts	acts	NNS	0
as	as	IN	0
an	an	DT	0
oncogene	oncogene	NN	B-NP
)	)	-RRB-	0
results	results	NNS	0
from	from	IN	0
both	both	PDT	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
nuclear	nuclear	JJ	0
retention	retention	NN	0
of	of	IN	0
liganded	liganded	JJ	B-NP
receptor	receptor	NN	I-NP
and	and	CC	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
gr	gr	NN	B-NP
protein	protein	NN	I-NP
reutilization	reutilization	NN	I-NP
that	that	IN	0
cycles	cycles	NNS	0
back	back	RB	0
into	into	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
.	.	.	0
Subsequently	Subsequently	RB	0
,	,	,	0
DeFranco	DeFranco	NNP	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
reported	reported	VBD	0
that	that	DT	0
treatment	treatment	NN	0
with	with	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
a	a	DT	0
potent	potent	FW	0
ser	ser	NNP	B-NP
/	/	NN	I-NP
thr	thr	NN	I-NP
protein	protein	NN	I-NP
phosphatase	phosphatase	NN	I-NP
inhibitor	inhibitor	NN	I-NP
,	,	,	0
also	also	RB	0
results	results	NNS	0
in	in	IN	0
inefficient	inefficient	JJ	0
nuclear	nuclear	JJ	0
retention	retention	NN	0
of	of	IN	0
agonist-bound	agonist-bound	NNP	B-NP
GR	GR	NNP	I-NP
and	and	CC	0
the	the	DT	0
cytoplasmic	cytoplasmic	JJ	0
"trapping	"trapping	NN	0
"	"	''	0
of	of	IN	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
in	in	IN	0
a	a	DT	0
form	form	NN	0
that	that	WDT	0
is	is	VBZ	0
unable	unable	JJ	0
to	to	TO	0
"recycle	"recycle	NNP	0
"	"	''	0
.	.	.	0
recent	recent	JJ	B-NP
study	study	NN	I-NP
with	with	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
suggest	suggest	VBP	0
phosphorylation	phosphorylation	RB	0
alters	alters	VB	0
the	the	DT	0
high	high	JJ	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
affinity	affinity	JJ	I-NP
binding	binding	NN	I-NP
to	to	TO	0
hsp-90	hsp-90	CD	B-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
an	an	DT	0
intact	intact	JJ	0
cytoskeleton	cytoskeleton	NN	B-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
ligand-activated	ligand-activated	NNP	B-NP
GR	GR	NNP	I-NP
translocation	translocation	NN	I-NP
through	through	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
[	[	-LRB-	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
ability	ability	NN	I-NP
to	to	TO	0
influence	influence	VB	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
intracellular	intracellular	JJ	I-NP
partitioning	partitioning	NN	I-NP
suggests	suggests	VBZ	0
that	that	IN	0
an	an	DT	0
sensitive	sensitive	JJ	B-NP
ser/thr	ser/thr	NN	I-NP
protein	protein	NN	I-NP
phosphatase	phosphatase	NN	I-NP
okadaic	okadaic	NN	I-NP
acid	acid	JJ	I-NP
(	(	-LRB-	0
PPase	PPase	NNP	0
)	)	-RRB-	0
participates	participates	VBZ	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
GR	GR	NNP	B-NP
movement	movement	NN	I-NP
.	.	.	0
In	In	IN	0
vitro	vitro	NN	B-NP
,	,	,	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
act	act	NN	I-NP
as	as	IN	0
a	a	DT	0
potent	potent	JJ	0
inhibitor	inhibitor	NN	0
of	of	IN	0
serine/threonine	serine/threonine	NN	B-NP
protein	protein	NN	I-NP
phosphata	phosphata	NN	I-NP
type	type	NN	0
1	1	CD	0
(	(	-LRB-	0
PP1	PP1	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
2A	2A	NNP	0
(	(	-LRB-	0
PP2A	PP2A	NNP	0
)	)	-RRB-	0
[	[	-LRB-	0
9	9	CD	0
,	,	,	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
Accordingly	Accordingly	RB	0
,	,	,	0
many	many	JJ	0
of	of	IN	0
the	the	DT	0
effects	effects	NNS	0
produced	produced	VBN	0
by	by	IN	0
the	the	DT	0
treatment	treatment	NN	0
of	of	IN	0
cells	cells	NNS	0
with	with	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
have	have	VBP	0
been	been	VBN	0
attributed	attributed	VBN	0
to	to	TO	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
these	these	DT	0
two	two	CD	0
enzymes	enzymes	NNS	0
.	.	.	0
However	However	RB	0
,	,	,	0
due	due	JJ	0
to	to	TO	0
toxicity	toxicity	VB	0
and	and	CC	0
solubility	solubility	JJ	B-NP
constraint	constraint	NN	I-NP
,	,	,	0
in	in	IN	0
living	living	VBG	B-NP
cell	cell	NN	I-NP
it	it	PRP	0
is	is	VBZ	0
difficult	difficult	JJ	0
to	to	TO	0
distinguish	distinguish	VB	0
the	the	DT	0
actions	actions	NNS	0
of	of	IN	0
PP2A	PP2A	CD	0
from	from	IN	0
those	those	DT	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
using	using	VBG	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
.	.	.	0
Furthermore	Furthermore	RB	0
,	,	,	0
in	in	IN	0
humans	humans	NNS	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
now	now	RB	0
clear	clear	JJ	0
that	that	IN	0
there	there	EX	0
are	are	VBP	0
four	four	CD	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
isoform	isoform	NN	I-NP
[	[	-LRB-	0
PP1α	PP1α	NNP	B-NP
,	,	,	0
PP1δ	PP1δ	NNP	B-NP
,	,	,	0
PP1γ	PP1γ	CD	B-NP
1	1	CD	0
and	and	CC	0
PP1γ	PP1γ	CD	B-NP
2	2	CD	0
[	[	-LRB-	0
11	11	CD	0
,	,	,	0
12	12	CD	0
,	,	,	0
13	13	CD	0
]	]	-RRB-	0
,	,	,	0
two	two	CD	0
isoform	isoform	NN	B-NP
of	of	IN	0
PP2A	PP2A	NNP	0
(	(	-LRB-	0
PP2A	PP2A	CD	0
α	α	NNS	0
and	and	CC	0
PP2Aβ	PP2Aβ	NNP	0
[	[	-LRB-	0
14	14	CD	0
,	,	,	0
15	15	CD	0
]	]	CD	0
)	)	-RRB-	0
and	and	CC	0
four	four	CD	0
structurally	structurally	CD	0
related	related	JJ	0
phosphata	phosphata	NN	B-NP
,	,	,	0
PP4	PP4	NNP	B-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
,	,	,	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
[	[	-LRB-	0
17	17	CD	0
,	,	,	0
18	18	CD	0
]	]	-RRB-	0
,	,	,	0
PP6	PP6	NNP	B-NP
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
and	and	CC	0
PP7	PP7	NNP	B-NP
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
detailed	detailed	JJ	0
dose-response	dose-response	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
not	not	RB	0
been	been	VBN	0
reported	reported	VBN	0
for	for	IN	0
native	native	JJ	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
,	,	,	0
PP6	PP6	NNP	B-NP
and	and	CC	0
PP7	PP7	NNP	B-NP
,	,	,	0
studies	studies	NNS	0
with	with	IN	0
PP4	PP4	NNP	B-NP
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
and	and	CC	0
recombinant	recombinant	JJ	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
indicate	indicate	VBP	0
they	they	PRP	0
are	are	VBP	0
also	also	RB	0
sensitive	sensitive	JJ	0
to	to	TO	0
okadaic	okadaic	VB	0
acid	acid	NN	B-NP
.	.	.	0
Like	Like	IN	0
calcineurin	calcineurin	NN	B-NP
(	(	-LRB-	0
PP2B	PP2B	NNP	0
)	)	-RRB-	0
and	and	CC	0
PP2C	PP2C	NNP	0
,	,	,	0
PP7	PP7	NNP	B-NP
is	is	VBZ	0
apparently	apparently	RB	0
insensitive	insensitive	VBN	0
to	to	TO	0
inhibition	inhibition	VB	0
by	by	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
recent	recent	JJ	B-NP
study	study	NN	I-NP
indicate	indicate	VBP	0
that	that	IN	0
pp5	pp5	NN	B-NP
associate	associate	JJ	I-NP
with	with	IN	0
the	the	DT	0
GR-hsp90	GR-hsp90	JJ	B-NP
complex	complex	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
,	,	,	0
23	23	CD	0
]	]	-RRB-	0
suggesting	suggesting	VBG	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
may	may	MD	0
influence	influence	VB	0
the	the	DT	0
actions	actions	NNS	0
of	of	IN	0
GRs	GRs	JJ	0
.	.	.	0
However	However	RB	0
,	,	,	0
studying	studying	VBG	0
the	the	DT	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
cellular	cellular	JJ	I-NP
role	role	NN	I-NP
has	has	VBZ	0
proven	proven	VBN	0
difficult	difficult	JJ	0
,	,	,	0
in	in	IN	0
part	part	NN	0
,	,	,	0
because	because	IN	0
no	no	DT	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
physiological	physiological	JJ	I-NP
substrate	substrate	NN	I-NP
have	have	VBP	0
been	been	VBN	0
identified	identified	VBN	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
in	in	IN	0
crude	crude	JJ	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
cell	cell	NN	I-NP
homogenate	homogenate	NN	I-NP
resides	resides	VBZ	0
predominately	predominately	VBN	0
in	in	IN	0
an	an	DT	0
inactive	inactive	JJ	B-NP
state	state	NN	I-NP
that	that	WDT	0
represents	represents	VBZ	0
<	<	SYM	0
1	1	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
measurable	measurable	JJ	0
PPase	PPase	JJ	B-NP
activity	activity	NN	I-NP
.	.	.	0
To	To	TO	0
characterize	characterize	VB	0
the	the	DT	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
cellular	cellular	JJ	I-NP
role	role	NN	I-NP
we	we	PRP	0
have	have	VBP	0
,	,	,	0
therefore	therefore	RB	0
,	,	,	0
developed	developed	VBD	B-NP
chimeric	chimeric	CD	I-NP
antisense	antisense	CD	I-NP
2	2	CD	0
'	'	''	0
-	-	:	0
O	O	NNP	0
-	-	:	0
(	(	-LRB-	0
2-methoxy	2-methoxy	NNP	0
)	)	-RRB-	0
ethylphosphothioate	ethylphosphothioate	JJ	0
oligonucleotides	oligonucleotides	JJ	0
capable	capable	JJ	0
of	of	IN	0
inhibiting	inhibiting	VBG	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
human	human	JJ	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
at	at	IN	0
nanomolar	nanomolar	JJ	B-NP
concentration	concentration	NN	I-NP
.	.	.	0
Because	Because	IN	0
the	the	DT	0
targeting	targeting	VBG	B-NP
pp5	pp5	NN	I-NP
lead	lead	JJ	I-NP
compound	compound	NN	I-NP
(	(	-LRB-	0
isi	isi	NN	B-NP
15534	15534	CD	0
)	)	-RRB-	0
acts	acts	VBZ	0
via	via	IN	0
RNAase	RNAase	NNP	B-NP
H	H	NNP	I-NP
mediated	mediated	JJ	0
degradation	degradation	NN	0
,	,	,	0
studies	studies	NNS	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
do	do	VBP	0
not	not	RB	0
allow	allow	VB	0
us	us	PRP	0
to	to	TO	0
assess	assess	VB	0
how	how	WRB	0
rapid	rapid	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
PP5	PP5	CD	B-NP
activity	activity	NN	I-NP
affect	affect	VB	0
cellular	cellular	JJ	B-NP
function	function	NN	I-NP
(	(	-LRB-	0
Northern	Northern	NNP	B-NP
analysis	analysis	NN	I-NP
indicate	indicate	VBP	0
that	that	IN	0
it	it	PRP	0
takes	takes	VBZ	0
~	~	CD	0
6	6	CD	0
for	for	IN	0
the	the	DT	0
mRNA	mRNA	JJ	B-NP
degradation	degradation	NN	I-NP
to	to	TO	0
occur	occur	VB	0
and	and	CC	0
,	,	,	0
due	due	JJ	0
to	to	TO	0
the	the	DT	0
preexisting	preexisting	JJ	B-NP
protein	protein	NN	I-NP
half-life	half-life	NN	I-NP
,	,	,	0
it	it	PRP	0
takes	takes	VBZ	0
~	~	CD	0
24	24	CD	0
hours	hours	NNS	0
for	for	IN	0
the	the	DT	0
protein	protein	NN	B-NP
level	level	JJ	I-NP
to	to	TO	0
fall	fall	VB	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
Nonetheless	Nonetheless	RB	0
,	,	,	0
isi	isi	NN	B-NP
15534	15534	CD	0
potently	potently	NNS	0
inhibits	inhibits	VBP	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
in	in	IN	0
cultured	cultured	JJ	0
cells	cells	NNS	0
for	for	IN	0
~	~	CD	0
48-72	48-72	CD	0
hours	hours	NNS	0
(	(	-LRB-	0
IC	IC	NNP	B-NP
50	50	CD	0
of	of	IN	0
<	<	SYM	0
75	75	CD	0
nm	nm	CD	B-NP
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
affords	affords	VBZ	0
a	a	DT	0
~	~	CD	0
24-48	24-48	CD	0
hour	hour	NN	0
window	window	NN	0
in	in	IN	0
which	which	WDT	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
is	is	VBZ	0
essentially	essentially	RB	0
ablated	ablated	JJ	0
[	[	-LRB-	0
24	24	CD	0
,	,	,	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
More	More	RBR	0
importantly	importantly	RB	0
,	,	,	0
because	because	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
has	has	VBZ	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
structurally	structurally	JJ	0
related	related	JJ	0
ppa	ppa	NN	B-NP
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
,	,	,	0
it	it	PRP	0
can	can	MD	0
be	be	VB	0
employed	employed	VBN	0
to	to	TO	0
specifically	specifically	RB	0
inhibit	inhibit	VB	0
the	the	DT	0
actions	actions	NNS	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
by	by	IN	0
suppressing	suppressing	CD	B-NP
pp5	pp5	NN	I-NP
protein	protein	NN	I-NP
level	level	JJ	I-NP
in	in	IN	0
cultured	cultured	JJ	0
human	human	JJ	0
cells	cells	NNS	0
.	.	.	0
To	To	TO	0
assess	assess	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
gr-mediated	gr-mediated	NN	B-NP
event	event	NN	I-NP
,	,	,	0
binding	binding	JJ	0
studies	studies	NNS	0
were	were	VBD	0
conducted	conducted	VBN	0
with	with	IN	0
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
dexamethasone	dexamethasone	VBZ	0
before	before	RB	0
and	and	CC	0
after	after	IN	0
isi	isi	NN	B-NP
15534-mediated	15534-mediated	NNP	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
.	.	.	0
These	These	DT	0
studies	studies	NNS	0
revealed	revealed	VBD	0
that	that	IN	0
the	the	DT	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
had	had	VBD	0
no	no	DT	0
apparent	apparent	JJ	0
effect	effect	NN	0
on	on	IN	0
dexamethasone	dexamethasone	JJ	B-NP
binding	binding	NN	I-NP
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
does	does	VBZ	0
not	not	RB	0
affect	affect	VB	0
the	the	DT	0
formation	formation	NN	0
of	of	IN	0
the	the	DT	0
ligand	ligand	JJ	B-NP
binding	binding	JJ	I-NP
complex	complex	NN	I-NP
high-affinity	high-affinity	JJ	I-NP
or	or	CC	0
hormone	hormone	NN	0
binding	binding	VBG	0
to	to	TO	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
mobility	mobility	JJ	B-NP
gel-shift	gel-shift	JJ	I-NP
analysis	analysis	NN	I-NP
revealed	revealed	VBD	0
that	that	DT	0
treatment	treatment	NN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
produces	produces	VBZ	0
a	a	DT	0
marked	marked	JJ	0
increase	increase	NN	0
in	in	IN	0
the	the	DT	0
association	association	NN	0
of	of	IN	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
with	with	IN	0
GRE-containing	GRE-containing	JJ	B-NP
DNA	DNA	NN	I-NP
,	,	,	0
and	and	CC	0
transient	transient	JJ	0
transfection	transfection	JJ	B-NP
study	study	NN	I-NP
employing	employing	VBG	0
a	a	DT	0
GR-responsive	GR-responsive	JJ	B-NP
reporter	reporter	NN	I-NP
plasmid	plasmid	VBZ	0
revealed	revealed	VBN	0
that	that	IN	0
the	the	DT	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
activates	activates	VBZ	0
GR-dependent	GR-dependent	JJ	B-NP
transcription	transcription	NN	I-NP
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
hormone	hormone	NN	0
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
When	When	WRB	0
a549	a549	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
and	and	CC	0
then	then	RB	0
dexamethasone	dexamethasone	JJ	0
,	,	,	0
the	the	DT	0
effect	effect	NN	0
was	was	VBD	0
additive	additive	CD	B-NP
,	,	,	0
with	with	IN	0
induced	induced	VBN	B-NP
luciferase	luciferase	NN	I-NP
activity	activity	NN	I-NP
maximal	maximal	JJ	I-NP
dexamethasone	dexamethasone	NN	I-NP
~	~	CD	0
10	10	CD	0
times	times	NNS	0
greater	greater	JJR	0
than	than	IN	0
the	the	DT	0
maximal	maximal	JJ	B-NP
dexamethasone-induced	dexamethasone-induced	JJ	I-NP
response	response	NN	I-NP
attainable	attainable	NN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Together	Together	RB	0
,	,	,	0
these	these	DT	0
studies	studies	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
pp5	pp5	NN	B-NP
act	act	NN	I-NP
as	as	IN	0
a	a	DT	0
suppressor	suppressor	NN	0
of	of	IN	0
GR-induced	GR-induced	JJ	B-NP
transcription	transcription	NN	I-NP
.	.	.	0
To	To	TO	0
further	further	RB	0
characterize	characterize	VB	0
the	the	DT	0
mechanism	mechanism	NN	0
by	by	IN	0
which	which	WDT	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
affects	affects	VBZ	0
GR	GR	NNP	B-NP
function	function	NN	I-NP
,	,	,	0
in	in	IN	0
the	the	DT	0
present	present	JJ	0
study	study	NN	0
we	we	PRP	0
employed	employed	VBD	0
a	a	DT	0
GR-GFP	GR-GFP	JJ	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
and	and	CC	0
fluorescent	fluorescent	JJ	0
microscopy	microscopy	NN	0
to	to	TO	0
follow	follow	VB	0
the	the	DT	0
movement	movement	NN	0
of	of	IN	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
in	in	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
dexamethasone	dexamethasone	NN	B-NP
and	and	CC	0
isi	isi	NN	B-NP
15534	15534	CD	0
.	.	.	0
These	These	DT	0
studies	studies	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
mediated	mediated	JJ	0
suppression	suppression	NN	0
of	of	IN	0
GR-function	GR-function	JJ	B-NP
arises	arises	NN	0
from	from	IN	0
the	the	DT	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
ability	ability	NN	I-NP
to	to	TO	0
suppress	suppress	VB	0
the	the	DT	0
nuclear	nuclear	JJ	0
accumulation	accumulation	NN	B-NP
of	of	IN	0
GRs	GRs	JJ	0
.	.	.	0
Results	Results	NNP	0
Inhibition	Inhibition	NNP	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
by	by	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	JJ	I-NP
Okadaic	Okadaic	JJ	I-NP
acid	acid	NN	I-NP
is	is	VBZ	0
widely	widely	RB	0
employed	employed	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
PPase	PPase	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
eukaryotic	eukaryotic	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
observed	observed	JJ	0
effects	effects	NNS	0
are	are	VBP	0
often	often	RB	0
attributed	attributed	VBN	0
to	to	TO	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
and	and	CC	0
PP2A	PP2A	NNP	0
.	.	.	0
However	However	RB	0
,	,	,	0
as	as	RB	0
seen	seen	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
1	1	CD	0
,	,	,	0
the	the	DT	0
phosphohistone	phosphohistone	NN	B-NP
dephosphorylation	dephosphorylation	NN	I-NP
by	by	IN	0
the	the	DT	0
catalytic	catalytic	JJ	B-NP
subunit	subunit	NN	I-NP
of	of	IN	0
purified	purified	JJ	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
from	from	IN	0
bovine	bovine	JJ	B-NP
brain	brain	NN	I-NP
is	is	VBZ	0
also	also	RB	0
potently	potently	JJ	0
inhibited	inhibited	NN	0
by	by	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
.	.	.	0
Okadaic	Okadaic	JJ	B-NP
acid	acid	NN	I-NP
inhibits	inhibits	VBD	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
in	in	IN	0
a	a	DT	0
dose-dependent	dose-dependent	JJ	B-NP
manner	manner	NN	I-NP
,	,	,	0
having	having	VBG	0
an	an	DT	0
IC	IC	NNP	B-NP
50	50	CD	0
of	of	IN	0
5.58	5.58	CD	0
+	+	CD	0
/	/	CD	0
-	-	:	0
0.41	0.41	CD	0
nM	nM	NN	B-NP
.	.	.	0
Under	Under	IN	0
identical	identical	JJ	0
assay	assay	JJ	B-NP
condition	condition	NN	I-NP
,	,	,	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
is	is	VBZ	0
a	a	DT	0
more	more	RBR	0
potent	potent	JJ	0
inhibitor	inhibitor	NN	0
of	of	IN	0
PP2A	PP2A	NNP	0
(	(	-LRB-	0
IC	IC	NNP	B-NP
50	50	CD	0
~	~	CD	0
0.05	0.05	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
and	and	CC	0
weaker	weaker	JJR	0
inhibitor	inhibitor	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
(	(	-LRB-	0
IC	IC	NNP	B-NP
50	50	CD	0
~	~	CD	0
45	45	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
against	against	IN	0
histona	histona	NN	B-NP
(	(	-LRB-	0
865	865	CD	0
+	+	CD	0
/	/	CD	0
-	-	:	0
31	31	CD	0
nMoles	nMoles	JJ	0
Pi	Pi	FW	0
/	/	FW	0
min	min	FW	0
/	/	FW	0
mg	mg	FW	0
protein	protein	FW	0
)	)	-RRB-	0
is	is	VBZ	0
less	less	JJR	0
than	than	IN	0
that	that	DT	0
of	of	IN	0
PP2A	PP2A	CD	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
whereas	whereas	IN	0
assays	assays	VBG	0
conducted	conducted	VBN	0
with	with	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
and	and	CC	0
PP2A	PP2A	NNP	0
were	were	VBD	0
conducted	conducted	VBN	0
with	with	IN	0
a	a	DT	0
enzyme	enzyme	NNS	B-NP
concentration	concentration	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
diluted	diluted	VBN	0
below	below	IN	0
the	the	DT	0
titration	titration	JJ	B-NP
endpoint	endpoint	NN	I-NP
(	(	-LRB-	0
defined	defined	VBN	0
as	as	IN	0
the	the	DT	0
enzyme	enzyme	NN	B-NP
concentration	concentration	NN	I-NP
after	after	IN	0
which	which	WDT	0
further	further	RB	0
dilution	dilution	VB	0
no	no	DT	0
longer	longer	RB	0
affects	affects	VBZ	0
the	the	DT	0
IC	IC	NNP	B-NP
50	50	CD	0
;	;	:	0
[	[	-LRB-	0
26	26	CD	0
]	]	CD	0
)	)	-RRB-	0
because	because	IN	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
upon	upon	IN	0
further	further	JJ	0
dilution	dilution	NN	0
was	was	VBD	0
below	below	IN	0
that	that	DT	0
necessary	necessary	JJ	0
for	for	IN	0
accurate	accurate	JJ	0
quantification	quantification	NN	B-NP
,	,	,	0
we	we	PRP	0
could	could	MD	0
not	not	RB	0
establish	establish	VB	0
a	a	DT	0
clear	clear	JJ	0
titration	titration	JJ	B-NP
endpoint	endpoint	NN	I-NP
with	with	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
titration	titration	JJ	B-NP
study	study	NN	I-NP
with	with	IN	0
microcystin-LR	microcystin-LR	JJ	B-NP
to	to	TO	0
estimate	estimate	VB	0
the	the	DT	0
actual	actual	JJ	0
amount	amount	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
in	in	IN	0
the	the	DT	0
reaction	reaction	NN	0
,	,	,	0
an	an	DT	0
estimate	estimate	NN	0
of	of	IN	0
the	the	DT	0
K	K	NNP	0
i	i	NN	0
for	for	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
is	is	VBZ	0
4.07	4.07	CD	0
+	+	CD	0
/	/	CD	0
-	-	:	0
0.16	0.16	CD	0
nM	nM	NN	B-NP
.	.	.	0
Still	Still	RB	0
,	,	,	0
it	it	PRP	0
should	should	MD	0
be	be	VB	0
kept	kept	VBN	0
in	in	IN	0
mind	mind	NN	0
that	that	IN	0
the	the	DT	0
true	true	JJ	0
K	K	NNP	0
i	i	FW	0
may	may	MD	0
be	be	VB	0
slightly	slightly	RB	0
lower	lower	JJR	0
.	.	.	0
Nonetheless	Nonetheless	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
clear	clear	JJ	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
is	is	VBZ	0
sensitive	sensitive	JJ	0
to	to	TO	0
inhibition	inhibition	VB	0
by	by	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
at	at	IN	0
the	the	DT	0
concentration	concentration	NN	B-NP
that	that	WDT	0
also	also	RB	0
affects	affects	VBZ	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
and	and	CC	0
PP2A	PP2A	NNP	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
when	when	WRB	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
is	is	VBZ	0
employed	employed	VBN	0
to	to	TO	0
treat	treat	VB	0
cells	cells	NNS	0
at	at	IN	0
a	a	DT	0
concentration	concentration	NN	B-NP
of	of	IN	0
>	>	NNP	0
1-5	1-5	NNP	0
nM	nM	NNP	0
,	,	,	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
is	is	VBZ	0
also	also	RB	0
affected	affected	VBN	0
.	.	.	0
isi	isi	NN	B-NP
15534	15534	CD	0
promotes	promotes	CD	0
nuclear	nuclear	JJ	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
localization	localization	NN	I-NP
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
the	the	DT	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
activity	activity	NN	I-NP
influenced	influenced	VBD	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
subcellular	subcellular	JJ	I-NP
distribution	distribution	NN	I-NP
,	,	,	0
plasmids	plasmids	VBZ	0
expressing	expressing	VBG	0
a	a	DT	0
GR-GFP	GR-GFP	JJ	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
were	were	VBD	0
microinjected	microinjected	VBN	0
into	into	IN	0
cells	cells	NNS	0
that	that	WDT	0
were	were	VBD	0
previously	previously	RB	0
treated	treated	VBN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
.	.	.	0
In	In	IN	0
these	these	DT	0
studies	studies	NNS	0
the	the	DT	0
GR-GFP	GR-GFP	JJ	B-NP
used	used	NN	I-NP
was	was	VBD	0
derived	derived	VBN	0
from	from	IN	0
the	the	DT	0
fusion	fusion	NN	0
of	of	IN	0
green	green	JJ	B-NP
fluorescent	fluorescent	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
to	to	TO	0
a	a	DT	0
GR	GR	NNP	B-NP
mutant	mutant	NN	I-NP
that	that	WDT	0
retained	retained	VBD	0
the	the	DT	0
ability	ability	NN	B-NP
to	to	TO	0
bind	bind	VB	0
agonist	agonist	NN	B-NP
,	,	,	0
translocate	translocate	VBG	0
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
and	and	CC	0
bind	bind	JJ	B-NP
DNA	DNA	NN	I-NP
,	,	,	0
but	but	CC	0
lacked	lacked	VBD	0
transactivation	transactivation	JJ	B-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
When	When	WRB	0
plasmid	plasmid	NN	B-NP
expressing	expressing	VBG	0
the	the	DT	0
GR-GFP	GR-GFP	NN	B-NP
were	were	VBD	0
injected	injected	VBN	0
into	into	IN	0
the	the	DT	0
nuclei	nuclei	NN	0
of	of	IN	0
cells	cells	NNS	0
and	and	CC	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
grown	grown	VBN	0
in	in	IN	0
serum-containing	serum-containing	JJ	0
medium	medium	NN	0
,	,	,	0
the	the	DT	0
majority	majority	NN	0
of	of	IN	0
the	the	DT	0
expressed	expressed	VBN	B-NP
GR-GFP	GR-GFP	JJ	I-NP
localized	localized	NN	I-NP
to	to	TO	0
the	the	DT	0
nuclei	nuclei	NN	0
of	of	IN	0
the	the	DT	0
injected	injected	JJ	0
cells	cells	NNS	0
,	,	,	0
as	as	RB	0
expected	expected	VBN	0
due	due	JJ	0
to	to	TO	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
glucocorticoid	glucocorticoid	NN	B-NP
in	in	IN	0
the	the	DT	0
serum	serum	NN	B-NP
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
after	after	IN	0
microinjection	microinjection	NN	B-NP
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
grown	grown	VBN	0
in	in	IN	0
medium	medium	JJ	0
supplemented	supplemented	NN	0
with	with	IN	0
serum	serum	NN	B-NP
for	for	IN	0
4	4	CD	0
to	to	TO	0
6	6	CD	0
hours	hours	NNS	0
and	and	CC	0
then	then	RB	0
serum	serum	VB	B-NP
starved	starved	VBN	0
overnight	overnight	JJ	0
to	to	TO	0
cause	cause	VB	0
the	the	DT	0
gr-gfp	gr-gfp	NN	B-NP
redistribution	redistribution	NN	I-NP
.	.	.	0
In	In	IN	0
the	the	DT	0
serum	serum	NN	B-NP
absence	absence	NN	I-NP
,	,	,	0
GR-GFP	GR-GFP	JJ	B-NP
localized	localized	NN	I-NP
throughout	throughout	IN	0
the	the	DT	0
cells	cells	NNS	0
,	,	,	0
with	with	IN	0
equal	equal	JJ	0
intensity	intensity	NN	0
in	in	IN	0
both	both	PDT	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
and	and	CC	0
cytoplasm	cytoplasm	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
.	.	.	0
Upon	Upon	IN	0
treatment	treatment	NN	0
of	of	IN	0
these	these	DT	0
cells	cells	NNS	0
with	with	IN	0
dexamethasona	dexamethasona	NN	B-NP
(	(	-LRB-	0
500	500	CD	0
nM	nM	NN	B-NP
for	for	IN	0
30	30	CD	0
minutes	minutes	NNS	0
)	)	-RRB-	0
the	the	DT	0
GR-GFP	GR-GFP	JJ	B-NP
efficiently	efficiently	JJ	0
translocated	translocated	NN	0
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
.	.	.	0
To	To	TO	0
assess	assess	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
in	in	IN	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
intracellular	intracellular	JJ	I-NP
partitioning	partitioning	NN	I-NP
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
or	or	CC	0
a	a	DT	0
mismatched	mismatched	JJ	B-NP
control	control	NN	I-NP
(	(	-LRB-	0
isi	isi	NN	B-NP
15521	15521	CD	0
)	)	-RRB-	0
at	at	IN	0
a	a	DT	0
concentration	concentration	NN	B-NP
of	of	IN	0
500	500	CD	0
nM	nM	NN	B-NP
,	,	,	0
which	which	WDT	0
essentially	essentially	RB	0
pp5	pp5	NN	B-NP
expression	expression	NN	I-NP
ablate	ablate	NN	I-NP
in	in	IN	0
a549	a549	NN	B-NP
cell	cell	NN	I-NP
after	after	IN	0
24	24	CD	0
hours	hours	NNS	0
[	[	-LRB-	0
24	24	CD	0
,	,	,	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Approximately	Approximately	RB	0
24	24	CD	0
hours	hours	NNS	0
after	after	IN	0
antisense	antisense	JJ	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
microinjected	microinjected	VBN	0
with	with	IN	0
pGR	pGR	NNP	B-NP
(	(	-LRB-	I-NP
Ala	Ala	NNP	I-NP
)	)	-RRB-	I-NP
-GFP	-GFP	JJ	I-NP
and	and	CC	0
subjected	subjected	VBN	0
to	to	TO	0
serum-starvation	serum-starvation	JJ	B-NP
as	as	IN	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
In	In	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
the	the	DT	0
mismatch	mismatch	JJ	B-NP
control	control	NN	I-NP
prior	prior	RB	I-NP
to	to	TO	0
microinjection	microinjection	VB	0
,	,	,	0
GR-GFP	GR-GFP	JJ	B-NP
expression	expression	NN	I-NP
was	was	VBD	0
indistinguishable	indistinguishable	VBN	0
from	from	IN	0
that	that	DT	0
in	in	IN	0
untreated	untreated	JJ	0
cells	cells	NNS	0
:	:	:	0
GR-GFP	GR-GFP	NNP	B-NP
was	was	VBD	0
distributed	distributed	VBN	0
evenly	evenly	RB	0
throughout	throughout	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
and	and	CC	0
nucleus	nucleus	NN	B-NP
(	(	-LRB-	0
Figure	Figure	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
following	following	VBG	0
treatment	treatment	NN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
,	,	,	0
GR-GFP	GR-GFP	NNP	B-NP
was	was	VBD	0
localized	localized	VBN	0
in	in	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
without	without	IN	0
dexamethasone	dexamethasone	JJ	B-NP
treatment	treatment	NN	I-NP
.	.	.	0
The	The	DT	0
percentage	percentage	NN	0
of	of	IN	0
cells	cells	NNS	0
displaying	displaying	VBG	0
predominantly	predominantly	RB	0
nuclear	nuclear	JJ	0
GR-GFP	GR-GFP	JJ	B-NP
or	or	CC	0
cytoplasmic	cytoplasmic	JJ	B-NP
GR-GFP	GR-GFP	NN	I-NP
from	from	IN	0
4	4	CD	0
independent	independent	JJ	0
experiments	experiments	NNS	0
were	were	VBD	0
tabulated	tabulated	JJ	0
and	and	CC	0
are	are	VBP	0
presented	presented	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
2B	2B	NNP	0
.	.	.	0
In	In	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
in	in	IN	0
the	the	DT	0
dexamethasone	dexamethasone	NN	B-NP
absence	absence	NN	I-NP
,	,	,	0
10	10	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
showed	showed	VBD	0
nuclear	nuclear	JJ	0
>	>	CD	0
gr-gfp	gr-gfp	NN	B-NP
cytoplasmic	cytoplasmic	JJ	I-NP
localization	localization	NN	I-NP
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
20	20	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
mismatch	mismatch	JJ	B-NP
oligonucleotide	oligonucleotide	NN	I-NP
displayed	displayed	VBD	0
greater	greater	JJR	0
nuclear	nuclear	JJ	0
than	than	IN	0
gr-gfp	gr-gfp	NN	B-NP
cytoplasmic	cytoplasmic	JJ	I-NP
localization	localization	NN	I-NP
.	.	.	0
By	By	IN	0
contrast	contrast	NN	0
,	,	,	0
the	the	DT	0
percentage	percentage	NN	0
of	of	IN	0
cells	cells	NNS	0
showing	showing	VBG	0
more	more	RBR	0
nuclear	nuclear	JJ	0
than	than	IN	0
gr-gfp	gr-gfp	NN	B-NP
cytoplasmic	cytoplasmic	JJ	I-NP
distribution	distribution	NN	I-NP
was	was	VBD	0
~	~	CD	0
93	93	CD	0
%	%	NN	0
,	,	,	0
~	~	CD	0
88	88	CD	0
%	%	NN	0
and	and	CC	0
~	~	CD	0
98	98	CD	0
%	%	NN	0
in	in	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
either	either	DT	0
dexamethasone	dexamethasone	NN	B-NP
,	,	,	0
isi	isi	NN	B-NP
15534	15534	CD	0
,	,	,	0
or	or	CC	0
isi	isi	NN	B-NP
15534	15534	CD	0
and	and	CC	0
dexamethasone	dexamethasone	NN	B-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
plays	plays	VBZ	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
nucleo-cytoplasmic	nucleo-cytoplasmic	JJ	I-NP
partitioning	partitioning	NN	I-NP
.	.	.	0
Inhibition	Inhibition	NNP	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
does	does	VBZ	0
not	not	RB	0
globally	globally	RB	0
affect	affect	VB	0
nuclear	nuclear	JJ	0
shuttling	shuttling	VBG	0
The	The	DT	0
isi	isi	NN	B-NP
ability	ability	NN	I-NP
15534	15534	CD	0
treatment	treatment	NN	0
to	to	TO	0
induce	induce	VB	0
the	the	DT	0
nuclear	nuclear	JJ	0
gr-gfp	gr-gfp	NN	B-NP
accumulation	accumulation	NN	I-NP
suggests	suggests	VBZ	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
influences	influences	VBZ	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
subcellular	subcellular	JJ	I-NP
distribution	distribution	NN	I-NP
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
could	could	MD	0
have	have	VB	0
a	a	DT	0
more	more	RBR	0
global	global	JJ	0
role	role	NN	0
,	,	,	0
possibly	possibly	RB	0
regulating	regulating	VBG	0
entire	entire	JJ	0
nuclear	nuclear	JJ	0
transport	transport	NN	B-NP
pathway	pathway	NN	I-NP
.	.	.	0
To	To	TO	0
test	test	VB	0
the	the	DT	0
latter	latter	NN	0
,	,	,	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
suppression	suppression	NN	I-NP
on	on	IN	0
the	the	DT	0
nucleo-cytoplasmic	nucleo-cytoplasmic	JJ	B-NP
shuttling	shuttling	NN	I-NP
of	of	IN	0
another	another	DT	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
,	,	,	0
NFAT	NFAT	NNP	B-NP
,	,	,	0
was	was	VBD	0
investigated	investigated	VBN	0
.	.	.	0
In	In	IN	0
these	these	DT	0
studies	studies	NNS	0
,	,	,	0
a	a	DT	0
stable	stable	JJ	0
GFP-NFAT	GFP-NFAT	JJ	B-NP
expressing	expressing	JJ	0
HeLa	HeLa	JJ	B-NP
cell	cell	NN	0
line	line	NN	0
was	was	VBD	0
employed	employed	VBN	0
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
As	As	RB	0
seen	seen	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
3	3	CD	0
,	,	,	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
any	any	DT	0
drug	drug	NN	0
,	,	,	0
the	the	DT	0
GFP-NFAT	GFP-NFAT	JJ	B-NP
protein	protein	NN	I-NP
is	is	VBZ	0
localized	localized	VBN	0
entirely	entirely	RB	0
within	within	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
.	.	.	0
Upon	Upon	IN	0
treatment	treatment	NN	0
with	with	IN	0
the	the	DT	0
ionophore	ionophore	JJ	B-NP
ionomycin	ionomycin	NN	I-NP
calcium	calcium	JJ	I-NP
,	,	,	0
gfp-nfat	gfp-nfat	NN	B-NP
translocate	translocate	NN	I-NP
rapidly	rapidly	RB	0
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
.	.	.	0
The	The	DT	0
fusion	fusion	NN	B-NP
protein	protein	NN	I-NP
then	then	RB	0
relocates	relocates	VBN	0
to	to	TO	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
if	if	IN	0
the	the	DT	0
drug	drug	NN	0
is	is	VBZ	0
washed	washed	VBN	0
out	out	RP	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
for	for	IN	0
6	6	CD	0
hours	hours	NNS	0
.	.	.	0
When	When	WRB	0
the	the	DT	0
GFP-NFAT	GFP-NFAT	JJ	B-NP
HeLa	HeLa	JJ	B-NP
cells	cells	NNS	0
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
,	,	,	0
the	the	DT	0
gfp-nfat	gfp-nfat	NN	B-NP
distribution	distribution	NN	I-NP
was	was	VBD	0
indistinguishable	indistinguishable	VBN	0
from	from	IN	0
untreated	untreated	JJ	0
cells	cells	NNS	0
or	or	CC	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
mismatched	mismatched	JJ	B-NP
control	control	NN	I-NP
oligonucleotide	oligonucleotide	NN	I-NP
.	.	.	0
Northern	Northern	JJ	B-NP
analysis	analysis	NN	I-NP
confirmed	confirmed	VBD	0
the	the	DT	0
isi	isi	NN	B-NP
ability	ability	NN	I-NP
15534	15534	CD	0
to	to	TO	0
suppress	suppress	VB	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
in	in	IN	0
hela	hela	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
the	the	DT	0
results	results	NNS	0
indicate	indicate	VBP	0
that	that	DT	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
does	does	VBZ	0
not	not	RB	0
have	have	VB	0
a	a	DT	0
global	global	JJ	0
effect	effect	NN	0
on	on	IN	0
all	all	DT	0
nuclear	nuclear	JJ	0
shuttling	shuttling	JJ	0
proteins	proteins	NNS	0
.	.	.	0
Discussion	Discussion	NN	0
Like	Like	IN	0
other	other	JJ	0
steroid	steroid	JJ	B-NP
hormone	hormone	NN	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
gr	gr	NN	B-NP
are	are	VBP	0
phosphoproteins	phosphoproteins	VBN	0
,	,	,	0
and	and	CC	0
reversible	reversible	JJ	0
phosphorylation	phosphorylation	NN	B-NP
of	of	IN	0
specific	specific	JJ	0
ser/thr	ser/thr	NN	B-NP
residue	residue	NN	I-NP
on	on	IN	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
or	or	CC	0
associated	associated	JJ	0
proteins	proteins	NNS	0
has	has	VBZ	0
been	been	VBN	0
implicated	implicated	VBN	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
1	1	CD	0
)	)	-RRB-	0
hormone	hormone	NN	0
binding	binding	VBG	0
to	to	TO	0
the	the	DT	0
cytoplasmic	cytoplasmic	JJ	B-NP
GR-complex	GR-complex	NN	I-NP
,	,	,	0
2	2	LS	0
)	)	-RRB-	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
translocation	translocation	NN	I-NP
between	between	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
and	and	CC	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
3	3	LS	0
)	)	-RRB-	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
ligand	ligand	JJ	B-NP
activated	activated	JJ	I-NP
GR	GR	NN	I-NP
to	to	TO	0
consensus	consensus	VB	B-NP
GRE	GRE	NNP	I-NP
in	in	IN	0
the	the	DT	0
gr-responsive	gr-responsive	NN	B-NP
gene	gene	NN	I-NP
promoter	promoter	NN	I-NP
region	region	NN	I-NP
,	,	,	0
and	and	CC	0
4	4	LS	0
)	)	-RRB-	0
the	the	DT	0
formation	formation	NN	0
of	of	IN	0
an	an	DT	0
active	active	JJ	0
transcriptional	transcriptional	JJ	B-NP
complex	complex	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
5	5	CD	0
,	,	,	0
6	6	CD	0
,	,	,	0
7	7	CD	0
,	,	,	0
8	8	CD	0
,	,	,	0
28	28	CD	0
,	,	,	0
29	29	CD	0
,	,	,	0
30	30	CD	0
,	,	,	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Many	Many	JJ	0
of	of	IN	0
the	the	DT	0
kinas	kinas	NNP	B-NP
that	that	IN	0
catalyze	catalyze	VBG	0
the	the	DT	0
phosphorylation	phosphorylation	NN	B-NP
of	of	IN	0
GRs	GRs	JJ	0
and	and	CC	0
associated	associated	JJ	0
proteins	proteins	NNS	0
have	have	VBP	0
been	been	VBN	0
identified	identified	VBN	0
.	.	.	0
However	However	RB	0
,	,	,	0
little	little	RB	0
is	is	VBZ	0
known	known	VBN	0
about	about	IN	0
the	the	DT	0
ppa	ppa	NN	B-NP
that	that	WDT	0
must	must	MD	0
also	also	RB	0
participate	participate	VB	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
GR-mediated	GR-mediated	JJ	B-NP
signaling	signaling	JJ	0
networks	networks	NNS	0
.	.	.	0
Several	Several	JJ	0
recent	recent	JJ	0
studies	studies	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
participates	participates	NN	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
GR-induced	GR-induced	JJ	B-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
.	.	.	0
First	First	NNP	0
,	,	,	0
dexamethasone-induced	dexamethasone-induced	JJ	B-NP
transcription	transcription	NN	I-NP
is	is	VBZ	0
markedly	markedly	RB	0
enhanced	enhanced	VBN	0
when	when	WRB	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
is	is	VBZ	0
suppressed	suppressed	VBN	0
by	by	IN	0
treatment	treatment	NN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Second	Second	LS	0
,	,	,	0
both	both	DT	0
co-immunoprecipitation	co-immunoprecipitation	JJ	B-NP
study	study	NN	I-NP
and	and	CC	0
studies	studies	NNS	0
with	with	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
mutant	mutant	JJ	I-NP
form	form	NN	I-NP
indicate	indicate	VBP	0
that	that	IN	0
pp5	pp5	NN	B-NP
associate	associate	JJ	I-NP
with	with	IN	0
the	the	DT	0
GR-hsp90	GR-hsp90	JJ	B-NP
complex	complex	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
,	,	,	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
binding	binding	JJ	0
assays	assays	NN	0
revealed	revealed	VBD	0
that	that	IN	0
the	the	DT	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
has	has	VBZ	0
no	no	DT	0
apparent	apparent	JJ	0
effect	effect	NN	0
on	on	IN	0
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
dexamethasone	dexamethasone	NN	B-NP
binding	binding	FW	0
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
appears	appears	VBZ	0
to	to	TO	0
act	act	VB	0
as	as	IN	0
a	a	DT	0
suppressor	suppressor	NN	0
of	of	IN	0
GR-induced	GR-induced	JJ	B-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
via	via	IN	0
a	a	DT	0
mechanism	mechanism	NN	0
that	that	WDT	0
does	does	VBZ	0
not	not	RB	0
alter	alter	VB	0
receptor	receptor	JJ	0
number	number	NN	0
or	or	CC	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
hormone	hormone	NN	0
to	to	TO	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
.	.	.	0
To	To	TO	0
further	further	RB	0
characterize	characterize	VB	0
the	the	DT	0
relationship	relationship	NN	B-NP
between	between	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
and	and	CC	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
in	in	IN	0
the	the	DT	0
present	present	JJ	0
study	study	NN	0
we	we	PRP	0
employed	employed	VBD	0
a	a	DT	0
GR-GFP	GR-GFP	JJ	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
to	to	TO	0
track	track	VB	0
the	the	DT	0
movement	movement	NN	0
of	of	IN	0
GRs	GRs	JJ	0
in	in	IN	0
a549	a549	NN	B-NP
cell	cell	NN	I-NP
following	following	VBG	0
treatment	treatment	NN	0
with	with	IN	0
hormones	hormones	NNS	0
or	or	CC	0
isi	isi	NN	B-NP
15534	15534	CD	0
.	.	.	0
These	These	DT	0
studies	studies	NNS	0
revealed	revealed	VBD	0
that	that	IN	0
in	in	IN	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
absence	absence	NN	I-NP
,	,	,	0
GR-GFP	GR-GFP	JJ	B-NP
localized	localized	NNS	0
mainly	mainly	RB	0
in	in	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
.	.	.	0
As	As	RB	0
expected	expected	VBN	0
,	,	,	0
treatment	treatment	NN	0
with	with	IN	0
dexamethasone	dexamethasone	JJ	B-NP
result	result	NN	I-NP
in	in	IN	0
the	the	DT	0
efficient	efficient	JJ	0
gr-gfp	gr-gfp	NN	B-NP
translocation	translocation	NN	I-NP
into	into	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
.	.	.	0
gr-gfp	gr-gfp	NN	B-NP
nuclear	nuclear	JJ	I-NP
accumulation	accumulation	NN	I-NP
was	was	VBD	0
also	also	RB	0
observed	observed	VBD	0
when	when	WRB	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
was	was	VBD	0
suppressed	suppressed	VBN	0
by	by	IN	0
treatment	treatment	NN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
after	after	IN	0
~	~	CD	0
24	24	CD	0
hours	hours	NNS	0
.	.	.	0
This	This	DT	0
gr-gfp	gr-gfp	NN	B-NP
translocation	translocation	NN	I-NP
occurred	occurred	VBD	0
without	without	IN	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
addition	addition	NN	I-NP
and	and	CC	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
serum	serum	JJ	B-NP
free	free	JJ	0
media	media	NNS	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
in	in	IN	0
the	the	DT	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
physiological	physiological	JJ	I-NP
concentration	concentration	NN	I-NP
absence	absence	NN	I-NP
,	,	,	0
GRs	GRs	JJ	0
accumulate	accumulate	NN	0
in	in	IN	0
the	the	DT	0
a549	a549	NN	B-NP
cell	cell	NN	I-NP
nucleus	nucleus	NN	I-NP
.	.	.	0
This	This	DT	0
finding	finding	NN	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
data	data	NNS	0
obtained	obtained	VBN	0
from	from	IN	0
gel-shift	gel-shift	JJ	B-NP
analysis	analysis	NN	I-NP
and	and	CC	0
transfection	transfection	JJ	B-NP
study	study	NN	I-NP
conducted	conducted	VBN	0
with	with	IN	0
gr-reporter	gr-reporter	NN	B-NP
plasmid	plasmid	NN	I-NP
,	,	,	0
where	where	WRB	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
pp5	pp5	NN	B-NP
level	level	JJ	I-NP
facilitates	facilitates	VBP	0
the	the	DT	0
association	association	NN	0
of	of	IN	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
with	with	IN	0
DNA	DNA	NNP	B-NP
and	and	CC	0
produces	produces	VBZ	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
GR-transactivation	GR-transactivation	NNP	B-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Together	Together	RB	0
,	,	,	0
these	these	DT	0
studies	studies	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
GR-induced	GR-induced	JJ	B-NP
transcriptional	transcriptional	JJ	I-NP
activity	activity	NN	I-NP
observed	observed	VBD	0
when	when	WRB	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
is	is	VBZ	0
suppressed	suppressed	VBN	0
by	by	IN	0
treatment	treatment	NN	0
with	with	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
results	results	NNS	0
from	from	IN	0
the	the	DT	0
nuclear	nuclear	JJ	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
accumulation	accumulation	NN	I-NP
.	.	.	0
The	The	DT	0
mechanism	mechanism	NN	0
by	by	IN	0
which	which	WDT	0
PP5	PP5	VBP	0
suppresses	suppresses	VBG	0
the	the	DT	0
nuclear	nuclear	JJ	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
accumulation	accumulation	NN	I-NP
is	is	VBZ	0
not	not	RB	0
clear	clear	JJ	0
.	.	.	0
The	The	DT	0
current	current	JJ	0
data	data	NN	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
acting	acting	VBG	0
to	to	TO	0
suppress	suppress	VB	0
the	the	DT	0
nuclear	nuclear	JJ	0
import	import	NN	0
of	of	IN	0
GRs	GRs	JJ	0
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
the	the	DT	0
data	data	NN	0
is	is	VBZ	0
also	also	RB	0
consistent	consistent	JJ	0
with	with	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
acting	acting	VBG	0
to	to	TO	0
promote	promote	VB	0
the	the	DT	0
nuclear	nuclear	JJ	0
export	export	NN	0
of	of	IN	0
the	the	DT	0
GRs	GRs	JJ	0
.	.	.	0
Because	Because	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
treatment	treatment	NN	0
are	are	VBP	0
not	not	RB	0
readily	readily	RB	0
reversible	reversible	JJ	0
,	,	,	0
the	the	DT	0
washout	washout	JJ	0
experiments	experiments	NNS	0
needed	needed	VBN	0
to	to	TO	0
distinguish	distinguish	VB	0
between	between	IN	0
these	these	DT	0
two	two	CD	0
possibilities	possibilities	NNS	0
cannot	cannot	RB	0
be	be	VB	0
conducted	conducted	VBN	0
until	until	IN	0
a	a	DT	0
specific	specific	JJ	0
and	and	CC	0
reversible	reversible	JJ	0
inhibitor	inhibitor	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
is	is	VBZ	0
developed	developed	VBN	0
.	.	.	0
recent	recent	JJ	B-NP
study	study	NN	I-NP
indicate	indicate	VBP	0
that	that	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
inhibits	inhibits	VBZ	0
nuclear	nuclear	JJ	0
transport	transport	NN	B-NP
mediated	mediated	NN	I-NP
by	by	IN	0
import	import	NN	B-NP
receptor	receptor	NN	I-NP
,	,	,	0
importin	importin	JJ	0
β	β	NN	0
and	and	CC	0
transportin	transportin	NN	B-NP
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
an	an	DT	0
okadaic	okadaic	JJ	B-NP
acid	acid	JJ	I-NP
sensitive	sensitive	JJ	I-NP
phosphatase	phosphatase	NN	I-NP
participates	participates	VBZ	0
in	in	IN	0
a	a	DT	0
mechanism	mechanism	NN	0
that	that	WDT	0
negatively	negatively	RB	0
regulates	regulates	VBZ	0
entire	entire	JJ	0
nuclear	nuclear	JJ	0
transport	transport	NN	B-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
Since	Since	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
is	is	VBZ	0
sensitive	sensitive	JJ	0
to	to	TO	0
inhibition	inhibition	VB	0
by	by	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
acted	acted	VBD	0
at	at	IN	0
a	a	DT	0
more	more	RBR	0
global	global	JJ	0
level	level	NN	0
by	by	IN	0
assessing	assessing	VBG	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
on	on	IN	0
the	the	DT	0
nfat-gfp	nfat-gfp	NN	B-NP
cellular	cellular	JJ	I-NP
distribution	distribution	NN	I-NP
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
to	to	TO	0
the	the	DT	0
findings	findings	NNS	0
obtained	obtained	VBN	0
with	with	IN	0
GR-GFP	GR-GFP	NNP	B-NP
,	,	,	0
the	the	DT	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
had	had	VBD	0
no	no	DT	0
apparent	apparent	JJ	0
effect	effect	NN	0
on	on	IN	0
calcium	calcium	JJ	B-NP
induced	induced	JJ	0
nuclear	nuclear	JJ	0
import	import	NN	0
or	or	CC	0
the	the	DT	0
subsequent	subsequent	JJ	0
export	export	NN	0
of	of	IN	0
NFAT-GFP	NFAT-GFP	NNP	B-NP
(	(	-LRB-	0
Figure	Figure	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
does	does	VBZ	0
not	not	RB	0
appear	appear	VB	0
to	to	TO	0
regulate	regulate	VB	0
entire	entire	JJ	0
nuclear	nuclear	JJ	0
transport	transport	NN	B-NP
pathway	pathway	NN	I-NP
.	.	.	0
Conclusions	Conclusions	NNS	0
These	These	DT	0
studies	studies	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
participates	participates	NN	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
GR	GR	NNP	B-NP
nucleocytoplasmic	nucleocytoplasmic	JJ	I-NP
shuttling	shuttling	NN	I-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
the	the	DT	0
suppression	suppression	NN	0
of	of	IN	0
pp5	pp5	NN	B-NP
expression	expression	NN	I-NP
result	result	NN	I-NP
in	in	IN	0
the	the	DT	0
nuclear	nuclear	JJ	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
accumulation	accumulation	NN	I-NP
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
hormone	hormone	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
the	the	DT	0
previously	previously	RB	0
reported	reported	VBN	B-NP
increase	increase	NN	I-NP
in	in	IN	0
GR-induced	GR-induced	JJ	B-NP
transcriptional	transcriptional	JJ	I-NP
activity	activity	NN	I-NP
that	that	WDT	0
occurs	occurs	VBZ	0
after	after	IN	0
isi	isi	NN	B-NP
15534	15534	CD	0
induced	induced	JJ	0
suppression	suppression	NN	0
of	of	IN	0
PP5	PP5	CD	B-NP
expression	expression	NN	I-NP
likely	likely	JJ	0
results	results	NNS	0
from	from	IN	0
the	the	DT	0
nuclear	nuclear	JJ	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
accumulation	accumulation	NN	I-NP
in	in	IN	0
a	a	DT	0
form	form	NN	0
that	that	WDT	0
is	is	VBZ	0
capable	capable	JJ	0
of	of	IN	0
binding	binding	JJ	0
DNA	DNA	NN	B-NP
yet	yet	RB	0
still	still	RB	0
requires	requires	VBZ	0
agonist	agonist	VBN	0
to	to	TO	0
elicit	elicit	FW	0
maximal	maximal	JJ	B-NP
transcriptional	transcriptional	NN	I-NP
activation	activation	NN	I-NP
.	.	.	0
Still	Still	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
not	not	RB	0
yet	yet	RB	0
clear	clear	JJ	0
if	if	IN	0
pp5	pp5	NN	B-NP
act	act	NN	I-NP
to	to	TO	0
suppress	suppress	VB	0
the	the	DT	0
nuclear	nuclear	JJ	0
accumulation	accumulation	NN	B-NP
or	or	CC	0
to	to	TO	0
facilitate	facilitate	VB	0
the	the	DT	0
nuclear	nuclear	JJ	0
export	export	NN	0
of	of	IN	0
GRs	GRs	JJ	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
precise	precise	JJ	0
molecular	molecular	JJ	B-NP
mechanism	mechanism	NN	I-NP
by	by	IN	0
which	which	WDT	0
PP5	PP5	VBP	0
suppresses	suppresses	VBG	0
the	the	DT	0
nuclear	nuclear	JJ	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
accumulation	accumulation	NN	I-NP
remains	remains	VBZ	0
to	to	TO	0
be	be	VB	0
elucidated	elucidated	NNS	0
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
Reagents	Reagents	NNP	0
Tissue	Tissue	NNP	0
culture	culture	NN	0
medium	medium	NN	0
,	,	,	0
Lipofectin	Lipofectin	NNP	B-NP
®and	®and	NNP	0
TRIzol	TRIzol	NNP	B-NP
®were	®were	NNP	0
purchased	purchased	VBD	0
from	from	IN	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
(	(	-LRB-	0
Gaithersburg	Gaithersburg	NNP	B-NP
,	,	,	0
MD	MD	NNP	0
)	)	-RRB-	0
.	.	.	0
DECEprime™	DECEprime™	NNP	B-NP
II	II	NNP	0
DNA	DNA	NNP	B-NP
labeling	labeling	NN	I-NP
,	,	,	0
and	and	CC	0
MAXIscript™	MAXIscript™	CD	B-NP
in	in	IN	0
vitro	vitro	JJ	B-NP
transcription	transcription	JJ	I-NP
kit	kit	NN	I-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Ambion	Ambion	NNP	B-NP
Inc	Inc	NNP	0
.	.	.	0
(	(	-LRB-	0
Austin	Austin	NNP	0
,	,	,	0
TX	TX	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
[	[	-LRB-	0
α-	α-	NNP	B-NP
32P	32P	NNP	I-NP
]	]	-RRB-	0
dATP	dATP	JJ	0
and	and	CC	0
[	[	-LRB-	0
α-	α-	NNP	B-NP
32P	32P	NNP	I-NP
]	]	-RRB-	0
UTP	UTP	NNP	B-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Dupont	Dupont	NNP	B-NP
NEN	NEN	NNP	I-NP
(	(	-LRB-	0
Boston	Boston	NNP	0
,	,	,	0
MA	MA	NNP	0
)	)	-RRB-	0
.	.	.	0
Protein	Protein	NN	B-NP
kinase	kinase	VBD	0
A	A	DT	0
(	(	-LRB-	0
3	3	LS	0
'	'	:	0
:	:	:	0
5	5	CD	0
'	'	POS	B-NP
-cyclic	-cyclic	JJ	I-NP
AMP	AMP	NNP	I-NP
dependent	dependent	JJ	0
)	)	-RRB-	0
,	,	,	0
phosphorylase	phosphorylase	NN	B-NP
b	b	NN	I-NP
(	(	-LRB-	0
EC	EC	NNP	B-NP
2.4.1.1	2.4.1.1	NNP	0
)	)	-RRB-	0
,	,	,	0
crude	crude	JJ	0
histona	histona	NN	B-NP
(	(	-LRB-	0
type	type	NN	B-NP
2a	2a	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
p-nitrophenyl	p-nitrophenyl	JJ	B-NP
phosphate	phosphate	NN	I-NP
(	(	-LRB-	0
PNPP	PNPP	NNP	B-NP
)	)	-RRB-	0
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
Sigma	Sigma	NNP	0
Chemical	Chemical	NNP	0
Company	Company	NNP	0
.	.	.	0
cell	cell	NN	B-NP
culture	culture	NN	I-NP
a549	a549	NN	I-NP
lung	lung	NN	I-NP
carcinoma	carcinoma	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
the	the	DT	0
American	American	NNP	0
Type	Type	NNP	B-NP
Tissue	Tissue	NNP	I-NP
Collection	Collection	NNP	I-NP
.	.	.	0
A	A	DT	0
stable	stable	JJ	0
HeLa	HeLa	JJ	B-NP
cell	cell	NN	0
line	line	NN	0
expressing	expressing	VBG	B-NP
GFP-NFAT	GFP-NFAT	NN	I-NP
was	was	VBD	0
generously	generously	RB	0
provided	provided	VBN	0
by	by	IN	0
Larry	Larry	NNP	0
Gerace	Gerace	NNP	0
(	(	-LRB-	0
The	The	DT	0
Scripps	Scripps	NNP	0
Research	Research	NNP	0
Institute	Institute	NNP	0
,	,	,	0
La	La	NNP	0
Jolla	Jolla	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
HeLa	HeLa	NNP	B-NP
and	and	CC	0
a549	a549	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
grown	grown	VBN	0
in	in	IN	0
Dulbecco	Dulbecco	NNP	0
's	's	POS	0
modified	modified	JJ	0
Eagle	Eagle	NNP	0
's	's	POS	0
medium	medium	NN	0
containing	containing	VBG	0
1	1	CD	0
g	g	NN	0
of	of	IN	0
glucose	glucose	NN	B-NP
/	/	NN	I-NP
liter	liter	NN	I-NP
(	(	-LRB-	0
DMEM	DMEM	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
10	10	CD	0
%	%	NN	0
heat-inactivated	heat-inactivated	NNP	0
fetal	fetal	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
.	.	.	0
All	All	DT	0
cell	cell	NN	0
cultures	cultures	NNS	0
were	were	VBD	0
routinely	routinely	RB	0
passed	passed	VBN	0
when	when	WRB	0
90-95	90-95	JJ	0
%	%	NN	0
confluent	confluent	NN	0
.	.	.	0
Oligonucleotide	Oligonucleotide	NNP	0
Synthesis	Synthesis	NNP	0
Assay	Assay	NNP	0
for	for	IN	0
Oligonucleotide	Oligonucleotide	NNP	0
Inhibition	Inhibition	NNP	0
of	of	IN	0
PP5	PP5	NNP	0
Expression	Expression	NNP	0
2	2	,	0
'	'	''	0
-	-	:	0
O	O	NNP	0
-	-	:	0
(	(	-LRB-	0
2-methoxy	2-methoxy	NNP	0
)	)	-RRB-	0
ethylphosphothioate	ethylphosphothioate	JJ	0
oligonucleotides	oligonucleotides	NN	0
were	were	VBD	0
synthesized	synthesized	JJ	0
and	and	CC	0
purified	purified	NN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
suppress	suppress	VB	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
,	,	,	0
the	the	DT	0
indicated	indicated	JJ	0
cells	cells	NNS	0
were	were	VBD	0
plated	plated	VBN	0
in	in	IN	0
60	60	CD	0
mm	mm	CD	0
dished	dished	NNS	0
and	and	CC	0
cultured	cultured	NN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
containing	containing	VBG	0
10	10	CD	0
%	%	NN	0
fc	fc	NN	B-NP
.	.	.	0
When	When	WRB	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
about	about	IN	0
70	70	CD	0
%	%	NN	0
confluent	confluent	NN	0
,	,	,	0
they	they	PRP	0
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
oligonucleotide	oligonucleotide	NN	B-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
24	24	CD	0
,	,	,	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
with	with	IN	0
DMEM	DMEM	NNP	B-NP
.	.	.	0
A	A	DT	0
solution	solution	NN	B-NP
(	(	-LRB-	0
1	1	CD	0
ml	ml	CD	0
)	)	-RRB-	0
of	of	IN	0
DMEM	DMEM	NNP	B-NP
containing	containing	VBG	0
the	the	DT	0
oligonucleotide	oligonucleotide	NN	B-NP
at	at	IN	0
the	the	DT	0
indicated	indicated	JJ	0
concentration	concentration	NN	B-NP
and	and	CC	0
15	15	CD	0
μg	μg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
DOTMA	DOTMA	NN	I-NP
/	/	NN	I-NP
DOPE	DOPE	NN	I-NP
(	(	-LRB-	0
Lipofectin	Lipofectin	NNP	B-NP
®	®	NNP	0
;	;	:	0
GIBCO-BRL	GIBCO-BRL	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
then	then	RB	0
added	added	VBD	0
.	.	.	0
After	After	IN	0
incubating	incubating	VBG	0
the	the	DT	0
cells	cells	NNS	0
at	at	IN	0
37°C	37°C	CD	0
for	for	IN	0
4	4	CD	0
hours	hours	NNS	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
and	and	CC	0
cultured	cultured	NN	0
in	in	IN	0
fresh	fresh	JJ	0
DMEM	DMEM	NN	B-NP
containing	containing	VBG	0
10	10	CD	0
%	%	NN	0
fc	fc	NN	B-NP
for	for	IN	0
17	17	CD	0
hours	hours	NNS	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
harvested	harvested	VBN	0
,	,	,	0
and	and	CC	0
total	total	JJ	B-NP
RNA	RNA	NNP	I-NP
was	was	VBD	0
extracted	extracted	VBN	0
with	with	IN	0
TRIzol	TRIzol	NNP	B-NP
Reagent	Reagent	NNP	I-NP
(	(	-LRB-	0
GIBCO-BRL	GIBCO-BRL	NNP	B-NP
)	)	-RRB-	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
methods	methods	NNS	0
of	of	IN	0
the	the	DT	0
manufacturer	manufacturer	NN	B-NP
.	.	.	0
Total	Total	JJ	B-NP
RNA	RNA	NNP	I-NP
(	(	-LRB-	0
20	20	CD	0
μg	μg	CD	B-NP
)	)	-RRB-	0
was	was	VBD	0
fractionated	fractionated	VBN	0
on	on	IN	0
1	1	CD	0
%	%	NN	0
agarosa	agarosa	NN	B-NP
gels	gels	VBP	0
containing	containing	VBG	B-NP
formaldehyde	formaldehyde	NN	I-NP
and	and	CC	0
transferred	transferred	VBN	0
to	to	TO	0
DURLON-UV	DURLON-UV	NNP	B-NP
(	(	-LRB-	0
Stratagene	Stratagene	NNP	B-NP
)	)	-RRB-	0
nylon	nylon	JJ	0
membranes	membranes	NN	0
.	.	.	0
Following	Following	VBG	0
UV	UV	NNP	B-NP
cross-linking	cross-linking	NNP	0
,	,	,	0
the	the	DT	0
filters	filters	NNS	0
were	were	VBD	0
hybridized	hybridized	VBN	0
with	with	IN	0
a	a	DT	0
[	[	-LRB-	0
32P	32P	NNP	0
]	]	-RRB-	0
probe	probe	NN	0
for	for	IN	0
human	human	JJ	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
.	.	.	0
The	The	DT	0
human	human	JJ	0
PP5	PP5	CD	B-NP
cDNA	cDNA	JJ	I-NP
probe	probe	NN	I-NP
was	was	VBD	0
generated	generated	VBN	0
from	from	IN	0
the	the	DT	0
full	full	JJ	0
protein	protein	NN	B-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	NN	I-NP
length	length	NN	I-NP
coding	coding	NN	I-NP
region	region	NN	I-NP
and	and	CC	0
[	[	-LRB-	0
32P	32P	NNP	0
]	]	-RRB-	0
labeled	labeled	VBN	0
with	with	IN	0
DECAprime	DECAprime	NNP	B-NP
®DNA	®DNA	NNP	0
Labeling	Labeling	NNP	B-NP
Kit	Kit	NNP	I-NP
(	(	-LRB-	0
Ambion	Ambion	NNP	B-NP
)	)	-RRB-	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
manufacturer	manufacturer	NN	0
's	's	POS	0
protocol	protocol	NN	0
.	.	.	0
Hybridization	Hybridization	NNP	B-NP
was	was	VBD	0
performed	performed	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
50	50	CD	0
%	%	NN	0
formamide	formamide	NN	B-NP
at	at	IN	0
42°C	42°C	CD	0
for	for	IN	0
16	16	CD	0
hours	hours	NNS	0
.	.	.	0
Following	Following	VBG	0
hybridization	hybridization	NN	B-NP
,	,	,	0
the	the	DT	0
membrane	membrane	NN	0
was	was	VBD	0
subjected	subjected	VBN	0
to	to	TO	0
two	two	CD	0
low	low	JJ	0
stringency	stringency	JJ	B-NP
wash	wash	NN	I-NP
(	(	-LRB-	0
2	2	CD	0
×	×	CD	0
SSC	SSC	NNP	B-NP
)	)	-RRB-	0
at	at	IN	0
room	room	NN	B-NP
temperature	temperature	NN	I-NP
and	and	CC	0
then	then	RB	0
two	two	CD	0
high	high	JJ	0
stringency	stringency	JJ	B-NP
wash	wash	NN	I-NP
(	(	-LRB-	0
0.1	0.1	CD	0
×	×	CD	0
SSC	SSC	CD	B-NP
/	/	CD	0
0.5	0.5	CD	0
%	%	NN	0
sd	sd	NN	B-NP
)	)	-RRB-	0
at	at	IN	0
55°C	55°C	CD	0
.	.	.	0
Hybridization	Hybridization	NNP	B-NP
was	was	VBD	0
visualized	visualized	VBN	0
by	by	IN	0
autoradiography	autoradiography	NN	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
filters	filters	NNS	0
were	were	VBD	0
then	then	RB	0
stripped	stripped	VBN	0
and	and	CC	0
reprobed	reprobed	NN	0
with	with	IN	0
a	a	DT	0
[	[	-LRB-	0
32P	32P	NNP	0
]	]	-RRB-	0
labeled	labeled	VBN	B-NP
glyceraldehyde-3-phosphate	glyceraldehyde-3-phosphate	NN	I-NP
dehydrogenase	dehydrogenase	NN	I-NP
(	(	-LRB-	0
GAPDH	GAPDH	NNP	B-NP
)	)	-RRB-	0
cDNA	cDNA	JJ	B-NP
probe	probe	NN	I-NP
to	to	TO	0
confirm	confirm	VB	0
equal	equal	JJ	0
loading	loading	NN	0
.	.	.	0
hybridization	hybridization	JJ	B-NP
signal	signal	JJ	I-NP
quantification	quantification	NN	I-NP
was	was	VBD	0
achieved	achieved	VBN	0
by	by	IN	0
analysis	analysis	NN	0
of	of	IN	0
the	the	DT	0
scanned	scanned	JJ	0
autoradiogram	autoradiogram	NN	B-NP
using	using	VBG	0
the	the	DT	0
NIH	NIH	NNP	B-NP
Image	Image	NNP	0
program	program	NN	0
(	(	-LRB-	0
ImagePC	ImagePC	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
histone	histone	NN	B-NP
phosphoprotein	phosphoprotein	NN	I-NP
substrate	substrate	NN	I-NP
preparation	preparation	NN	I-NP
(	(	-LRB-	0
type	type	NN	B-NP
2a	2a	NN	I-NP
from	from	IN	0
Sigma	Sigma	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
phosphorylated	phosphorylated	VBN	0
with	with	IN	0
cAMP-dependent	cAMP-dependent	JJ	B-NP
protein	protein	NN	I-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
protein	protein	NN	B-NP
kinase	kinase	NN	I-NP
A	A	NNP	0
)	)	-RRB-	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
20	20	CD	0
histone	histone	NN	B-NP
mg	mg	NN	I-NP
was	was	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
1	1	CD	0
protein	protein	NN	B-NP
mg	mg	NN	I-NP
kinase	kinase	VBD	0
A	A	DT	0
,	,	,	0
in	in	IN	0
a	a	DT	0
20	20	CD	0
mM	mM	JJ	B-NP
Tris-Cl	Tris-Cl	JJ	I-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.4	7.4	CD	0
)	)	-RRB-	0
containing	containing	VBG	0
1	1	CD	0
mCi	mCi	NNS	0
[	[	-LRB-	0
32P	32P	NNP	0
]	]	-RRB-	0
ATP	ATP	NNP	B-NP
(	(	-LRB-	0
150	150	CD	0
μM	μM	JJ	B-NP
ATP	ATP	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
100	100	CD	0
μM	μM	JJ	B-NP
cAMP	cAMP	NN	I-NP
,	,	,	0
5	5	CD	0
mM	mM	JJ	B-NP
DTT	DTT	NNP	I-NP
,	,	,	0
and	and	CC	0
5	5	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	B-NP
2	2	CD	0
in	in	IN	0
a	a	DT	0
final	final	JJ	B-NP
volume	volume	NN	I-NP
of	of	IN	0
4	4	CD	0
ml	ml	NNS	0
.	.	.	0
The	The	DT	0
reaction	reaction	NN	0
was	was	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
continue	continue	VB	0
for	for	IN	0
3.5	3.5	CD	0
to	to	TO	0
4	4	CD	0
hr	hr	NN	B-NP
at	at	IN	0
30°C	30°C	NNP	0
and	and	CC	0
terminated	terminated	VBN	0
by	by	IN	0
the	the	DT	0
addition	addition	NN	B-NP
of	of	IN	0
1.3	1.3	CD	0
ml	ml	NN	0
of	of	IN	0
100	100	CD	0
%	%	NN	0
TCA	TCA	NNP	B-NP
.	.	.	0
The	The	DT	0
precipitated	precipitated	JJ	0
phosphohistone	phosphohistone	NN	B-NP
was	was	VBD	0
collected	collected	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
at	at	IN	0
3000	3000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
.	.	.	0
The	The	DT	0
supernatant	supernatant	NN	B-NP
was	was	VBD	0
discarded	discarded	VBN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
pellet	pellet	NN	0
was	was	VBD	0
redissolved	redissolved	VBN	0
in	in	IN	0
4	4	CD	0
ml	ml	NN	0
of	of	IN	0
1	1	CD	0
M	M	NNP	0
Tris-Cl	Tris-Cl	NNP	B-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
8.2	8.2	CD	0
)	)	-RRB-	0
.	.	.	0
TCA	TCA	NNP	B-NP
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
precipitate	precipitate	VB	0
the	the	DT	0
phosphohistone	phosphohistone	NN	B-NP
,	,	,	0
and	and	CC	0
this	this	DT	0
precipitation-resuspension	precipitation-resuspension	JJ	B-NP
wash	wash	NN	I-NP
was	was	VBD	0
repeated	repeated	VBN	0
5	5	CD	0
times	times	NNS	0
.	.	.	0
The	The	DT	0
pellet	pellet	NN	0
produced	produced	VBN	0
upon	upon	IN	0
the	the	DT	0
sixth	sixth	JJ	0
TCA	TCA	NNP	B-NP
precipitation	precipitation	NN	I-NP
was	was	VBD	0
washed	washed	VBN	0
2	2	CD	0
times	times	NNS	0
with	with	IN	0
4	4	CD	0
ml	ml	NN	0
of	of	IN	0
ethanol	ethanol	NN	B-NP
:	:	:	0
ethyl	ethyl	NN	B-NP
ether	ether	NN	I-NP
(	(	-LRB-	0
1	1	LS	0
:	:	:	0
4	4	LS	0
;	;	:	0
v	v	CD	0
:	:	:	0
v	v	LS	0
)	)	-RRB-	0
and	and	CC	0
then	then	RB	0
2	2	CD	0
additional	additional	JJ	0
times	times	NNS	0
with	with	IN	0
acidified	acidified	JJ	0
ethanol	ethanol	NN	B-NP
:	:	:	0
ethyl	ethyl	NN	B-NP
ether	ether	NN	I-NP
(	(	-LRB-	0
1	1	LS	0
:	:	:	0
4	4	LS	0
;	;	:	0
0.1	0.1	CD	0
N	N	NNP	B-NP
HCl	HCl	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
washed	washed	JJ	0
histone	histone	NN	B-NP
was	was	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
air	air	VB	0
dry	dry	JJ	0
and	and	CC	0
was	was	VBD	0
then	then	RB	0
resuspended	resuspended	VBN	0
in	in	IN	0
5	5	CD	0
mM	mM	JJ	B-NP
Tris-Cl	Tris-Cl	NN	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.4	7.4	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
procedure	procedure	NN	B-NP
yield	yield	NN	I-NP
phosphohistone	phosphohistone	VBN	0
with	with	IN	0
a	a	DT	0
specific	specific	JJ	0
activity	activity	NN	0
>	>	CD	0
4.5	4.5	CD	0
×	×	CD	0
10	10	CD	0
6CPM	6CPM	CD	0
/	/	CD	0
nMole	nMole	JJ	B-NP
incorporated	incorporated	JJ	I-NP
phosphate	phosphate	NN	I-NP
.	.	.	0
phosphatase	phosphatase	JJ	B-NP
activity	activity	NN	I-NP
phosphatase	phosphatase	JJ	I-NP
activity	activity	NN	I-NP
determination	determination	NN	I-NP
against	against	IN	0
phosphohistone	phosphohistone	NN	B-NP
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
the	the	DT	0
quantification	quantification	NN	B-NP
of	of	IN	0
[	[	-LRB-	0
32P	32P	NNP	0
]	]	-RRB-	0
liberation	liberation	NN	0
from	from	IN	0
phosphohistone	phosphohistone	VBG	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
.	.	.	0
Assays	Assays	NNP	0
,	,	,	0
80	80	CD	0
μl	μl	CD	B-NP
total	total	JJ	I-NP
volume	volume	NN	I-NP
,	,	,	0
containing	containing	VBG	0
50	50	CD	0
mM	mM	JJ	B-NP
Tris-HCl	Tris-HCl	NN	I-NP
,	,	,	0
pH	pH	JJ	0
7.4	7.4	CD	0
,	,	,	0
0.5	0.5	CD	0
mM	mM	JJ	B-NP
DTT	DTT	NNP	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
,	,	,	0
100	100	CD	0
μM	μM	JJ	B-NP
oleic	oleic	JJ	I-NP
acid	acid	NN	I-NP
(	(	-LRB-	0
assay	assay	NN	B-NP
buffer	buffer	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
[	[	-LRB-	0
32P	32P	NNP	0
]	]	-RRB-	0
phosphoprotein	phosphoprotein	NN	B-NP
(	(	-LRB-	0
1-2	1-2	NNP	0
μM	μM	NNP	0
PO	PO	NNP	0
4	4	CD	0
)	)	-RRB-	0
,	,	,	0
were	were	VBD	0
conducted	conducted	VBN	0
at	at	IN	0
37°C	37°C	NNP	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
using	using	VBG	0
PP5	PP5	CD	B-NP
purified	purified	NN	I-NP
from	from	IN	0
bovine	bovine	JJ	B-NP
brain	brain	NN	I-NP
.	.	.	0
The	The	DT	0
serine	serine	NN	B-NP
/	/	NN	I-NP
threonine	threonine	NN	I-NP
protein	protein	NN	I-NP
phosphatase	phosphatase	NN	I-NP
type	type	NN	I-NP
5	5	CD	0
(	(	-LRB-	0
PP5	PP5	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
purified	purified	VBN	0
from	from	IN	0
bovine	bovine	JJ	B-NP
brain	brain	NN	I-NP
according	according	VBG	0
to	to	TO	0
the	the	DT	0
following	following	JJ	0
procedure	procedure	NN	0
:	:	:	0
a	a	DT	0
bovine	bovine	JJ	B-NP
brain	brain	NN	I-NP
was	was	VBD	0
homogenized	homogenized	VBN	B-NP
in	in	IN	0
~	~	CD	0
3	3	CD	0
volumes	volumes	NNS	0
of	of	IN	0
buffer	buffer	VBG	B-NP
A	A	DT	0
(	(	-LRB-	0
50	50	CD	0
ph	ph	NN	B-NP
mm	mm	NN	I-NP
hepe	hepe	NN	I-NP
7.5	7.5	CD	0
4°C	4°C	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
,	,	,	0
10	10	CD	0
mM	mM	JJ	B-NP
PMSF	PMSF	NNP	I-NP
and	and	CC	0
0.1	0.1	CD	0
%	%	NN	0
2-mercaptoethanol	2-mercaptoethanol	CD	0
)	)	-RRB-	0
and	and	CC	0
subjected	subjected	VBN	0
to	to	TO	0
centrifugation	centrifugation	VB	0
at	at	IN	0
15,000	15,000	CD	0
g	g	NN	0
for	for	IN	0
40	40	CD	0
min.	min.	CD	B-NP
followed	followed	VBN	0
by	by	IN	0
a	a	DT	0
45	45	CD	0
%	%	NN	0
-60	-60	CD	0
%	%	NN	0
supernatant	supernatant	NN	B-NP
ammonium	ammonium	NN	I-NP
sulfate	sulfate	NN	I-NP
fractionation	fractionation	NN	I-NP
.	.	.	0
The	The	DT	0
pellets	pellets	NN	0
from	from	IN	0
the	the	DT	0
ammonium	ammonium	JJ	B-NP
sulfate	sulfate	JJ	I-NP
fractionation	fractionation	NN	I-NP
were	were	VBD	0
resuspended	resuspended	VBN	0
in	in	IN	0
60	60	CD	0
ml	ml	NN	0
of	of	IN	0
buffer	buffer	JJ	B-NP
B	B	NNP	I-NP
(	(	-LRB-	0
20	20	CD	0
ph	ph	NN	B-NP
mm	mm	NN	I-NP
hepe	hepe	NN	I-NP
8.5	8.5	CD	0
4°C	4°C	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
,	,	,	0
and	and	CC	0
0.1	0.1	CD	0
%	%	NN	0
2-mercaptoethanol	2-mercaptoethanol	CD	0
)	)	-RRB-	0
,	,	,	0
desalted	desalted	VBG	0
on	on	IN	0
a	a	DT	0
sephadex	sephadex	JJ	B-NP
column	column	NN	I-NP
g-25	g-25	NN	I-NP
equilibrated	equilibrated	NN	0
with	with	IN	0
buffer	buffer	JJ	B-NP
B	B	NNP	I-NP
,	,	,	0
then	then	RB	0
subjected	subjected	VBN	0
to	to	TO	0
sequential	sequential	VB	0
chromatography	chromatography	VBN	0
on	on	IN	0
a	a	DT	0
5	5	CD	0
ml	ml	CD	0
HiTrap	HiTrap	JJ	B-NP
Heparin	Heparin	JJ	I-NP
column	column	NN	I-NP
(	(	-LRB-	0
Pharmacia	Pharmacia	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
a	a	DT	0
5	5	CD	0
ml	ml	CD	0
HiTrap	HiTrap	JJ	B-NP
Q	Q	NNP	I-NP
column	column	NN	I-NP
(	(	-LRB-	0
Pharmacia	Pharmacia	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
a	a	DT	0
HiTrap	HiTrap	JJ	B-NP
SP	SP	NNP	I-NP
column	column	NN	I-NP
(	(	-LRB-	0
Pharmacia	Pharmacia	NNP	B-NP
)	)	-RRB-	0
respectively	respectively	RB	0
.	.	.	0
The	The	DT	0
eluate	eluate	NN	B-NP
from	from	IN	0
the	the	DT	0
SP	SP	NNP	B-NP
column	column	NN	I-NP
was	was	VBD	0
then	then	RB	0
diluted	diluted	VBN	0
5-fold	5-fold	CD	0
with	with	IN	0
buffer	buffer	JJ	B-NP
C	C	NNP	I-NP
(	(	-LRB-	0
20	20	CD	0
mM	mM	JJ	0
tris	tris	JJ	B-NP
pH	pH	JJ	I-NP
8.5	8.5	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
and	and	CC	0
0.1	0.1	CD	0
%	%	NN	0
2-mercaptoethanol	2-mercaptoethanol	CD	0
)	)	-RRB-	0
and	and	CC	0
subjected	subjected	VBN	0
to	to	TO	0
anion-exchange	anion-exchange	JJ	B-NP
chromatography	chromatography	NN	I-NP
on	on	IN	0
a	a	DT	0
BioScale	BioScale	JJ	B-NP
Q	Q	NNP	I-NP
column	column	NN	I-NP
(	(	-LRB-	0
2	2	CD	0
ml	ml	NN	0
from	from	IN	0
BioRad	BioRad	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
All	All	DT	0
steps	steps	NNS	0
in	in	IN	0
the	the	DT	0
purification	purification	JJ	B-NP
procedure	procedure	NN	I-NP
were	were	VBD	0
performed	performed	VBN	0
at	at	IN	0
4°C	4°C	CD	0
except	except	IN	0
for	for	IN	0
the	the	DT	0
last	last	JJ	0
step	step	NN	0
which	which	WDT	0
was	was	VBD	0
performed	performed	VBN	0
at	at	IN	0
23°C	23°C	CD	0
.	.	.	0
PP5	PP5	NNP	B-NP
activity	activity	NN	I-NP
was	was	VBD	0
followed	followed	VBN	0
during	during	IN	0
the	the	DT	0
purification	purification	NN	B-NP
by	by	IN	0
assaying	assaying	NN	0
for	for	IN	0
trypsin-stimulated	trypsin-stimulated	JJ	B-NP
phosphohydrolase	phosphohydrolase	JJ	I-NP
activity	activity	NN	I-NP
at	at	IN	0
37°C	37°C	FW	0
vs.	vs.	FW	0
p-nitrophenyl	p-nitrophenyl	NN	B-NP
phosphate	phosphate	NN	I-NP
in	in	IN	0
200	200	CD	0
μl	μl	CD	B-NP
reaction	reaction	NN	I-NP
containing	containing	VBG	0
:	:	:	0
25	25	CD	0
mM	mM	JJ	0
tris	tris	JJ	0
pH	pH	JJ	0
8.3	8.3	CD	0
,	,	,	0
25	25	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	0
2	2	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	0
DTT	DTT	NNP	0
and	and	CC	0
10	10	CD	0
mM	mM	JJ	0
p-nitrophenyl	p-nitrophenyl	JJ	0
phosphate	phosphate	NN	0
.	.	.	0
dephosphorylation	dephosphorylation	NN	B-NP
reaction	reaction	NN	I-NP
were	were	VBD	0
routinely	routinely	RB	0
conducted	conducted	VBN	0
for	for	IN	0
10	10	CD	0
minutes	minutes	NNS	0
and	and	CC	0
initiated	initiated	VBN	0
with	with	IN	0
the	the	DT	0
addition	addition	NN	B-NP
of	of	IN	0
substrate	substrate	NN	0
.	.	.	0
The	The	DT	0
dephosphorylation	dephosphorylation	NN	B-NP
of	of	IN	0
substrate	substrate	NN	0
was	was	VBD	0
kept	kept	VBN	0
to	to	TO	0
less	less	JJR	0
than	than	IN	0
10	10	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
total	total	JJ	B-NP
phosphorylated	phosphorylated	JJ	I-NP
substrate	substrate	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
reaction	reaction	NN	0
was	was	VBD	0
linear	linear	VBN	0
with	with	IN	0
respect	respect	NN	0
to	to	TO	0
enzyme	enzyme	VB	B-NP
concentration	concentration	NN	I-NP
and	and	CC	0
time.	time.	NNP	0
[	[	-LRB-	0
32P	32P	NNP	0
]	]	-RRB-	0
phosphate	phosphate	JJ	0
liberated	liberated	NN	0
by	by	IN	0
the	the	DT	0
enzymes	enzymes	NN	0
was	was	VBD	0
extracted	extracted	VBN	0
as	as	IN	0
a	a	DT	0
phosphomolybdate	phosphomolybdate	JJ	B-NP
complex	complex	NN	I-NP
and	and	CC	0
measured	measured	VBN	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
methods	methods	NNS	0
of	of	IN	0
Killilea	Killilea	NNP	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
Inhibition	Inhibition	NNP	0
of	of	IN	0
phosphatase	phosphatase	JJ	B-NP
activity	activity	NN	I-NP
by	by	IN	0
okadaic	okadaic	JJ	B-NP
acid	acid	NN	I-NP
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
adding	adding	VBG	0
the	the	DT	0
inhibitors	inhibitors	NN	0
to	to	TO	0
the	the	DT	0
enzyme	enzyme	JJ	B-NP
mixture	mixture	NN	I-NP
10	10	CD	0
minutes	minutes	NNS	0
prior	prior	RB	0
to	to	TO	0
initiating	initiating	VB	0
the	the	DT	0
reaction	reaction	NN	0
with	with	IN	0
the	the	DT	0
addition	addition	NN	B-NP
of	of	IN	0
substrate	substrate	NN	0
.	.	.	0
gr-gfp	gr-gfp	NN	B-NP
expression	expression	NN	I-NP
vector	vector	NN	I-NP
A	A	DT	0
mutant	mutant	JJ	B-NP
rat	rat	NN	I-NP
glucocorticoid	glucocorticoid	NN	I-NP
receptor	receptor	NN	I-NP
that	that	WDT	0
retained	retained	VBD	B-NP
hormone	hormone	JJ	I-NP
binding	binding	NN	I-NP
,	,	,	0
nuclear	nuclear	JJ	0
translocation	translocation	JJ	B-NP
activity	activity	NN	I-NP
,	,	,	0
and	and	CC	0
specific	specific	JJ	0
DNA	DNA	NN	B-NP
binding	binding	JJ	0
activity	activity	NN	0
,	,	,	0
but	but	CC	0
was	was	VBD	0
incapable	incapable	VBN	0
of	of	IN	0
transactivation	transactivation	NN	B-NP
was	was	VBD	0
fused	fused	VBN	0
to	to	TO	0
a	a	DT	0
S65T	S65T	JJ	0
mutant	mutant	NN	0
of	of	IN	0
green	green	JJ	0
fluorescent	fluorescent	JJ	0
protein	protein	NN	B-NP
to	to	TO	0
create	create	VB	0
pGR	pGR	JJ	B-NP
(	(	-LRB-	I-NP
Ala	Ala	NNP	I-NP
)	)	-RRB-	I-NP
-GFP	-GFP	JJ	I-NP
.	.	.	0
GR	GR	NNP	B-NP
(	(	-LRB-	I-NP
Ala	Ala	NNP	I-NP
)	)	-RRB-	I-NP
-GFP	-GFP	JJ	I-NP
expression	expression	NN	I-NP
is	is	VBZ	0
driven	driven	VBN	0
by	by	IN	0
the	the	DT	0
CMV	CMV	NNP	0
immediate	immediate	JJ	0
early	early	JJ	0
promoter	promoter	NN	0
and	and	CC	0
enhancer	enhancer	NN	B-NP
.	.	.	0
All	All	DT	0
manipulation	manipulation	NN	B-NP
were	were	VBD	0
performed	performed	VBN	0
as	as	RB	0
described	described	VBN	0
,	,	,	0
and	and	CC	0
all	all	DT	0
constructs	constructs	NN	0
were	were	VBD	0
confirmed	confirmed	VBN	0
by	by	IN	0
sequencing	sequencing	NN	B-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
plasmid	plasmid	JJ	B-NP
dna	dna	NN	I-NP
protein-free	protein-free	NN	I-NP
was	was	VBD	0
purified	purified	VBN	0
using	using	VBG	0
qiagen	qiagen	NN	B-NP
maxiprep	maxiprep	JJ	I-NP
column	column	NN	I-NP
(	(	-LRB-	0
San	San	NNP	0
Diego	Diego	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
contained	contained	VBD	0
predominantly	predominantly	RB	0
supercoiled	supercoiled	JJ	B-NP
plasmid	plasmid	NN	I-NP
with	with	IN	0
no	no	DT	0
contaminating	contaminating	JJ	0
rrnas,	rrnas,	NN	B-NP
or	or	CC	0
low	low	JJ	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
contaminant	contaminant	NN	I-NP
.	.	.	0
translocation	translocation	JJ	B-NP
cell	cell	NN	I-NP
gfp-gr	gfp-gr	NN	I-NP
were	were	VBD	0
plated	plated	VBN	0
on	on	IN	0
etched	etched	JJ	0
coverslip	coverslip	NN	B-NP
and	and	CC	0
grown	grown	VBN	0
until	until	IN	0
the	the	DT	0
cultures	cultures	NNS	0
were	were	VBD	0
~	~	CD	0
70	70	CD	0
%	%	NN	0
confluent	confluent	NN	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
either	either	RB	0
treated	treated	VBN	0
with	with	IN	0
oligonucleotides	oligonucleotides	VBG	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
or	or	CC	0
left	left	VBD	0
untreated	untreated	VBN	0
.	.	.	0
Eighteen	Eighteen	JJ	0
hours	hours	NNS	0
later	later	RB	0
,	,	,	0
purified	purified	JJ	0
protein-free	protein-free	JJ	B-NP
pGR	pGR	NN	I-NP
(	(	-LRB-	I-NP
Ala	Ala	NNP	I-NP
)	)	-RRB-	I-NP
-GFP	-GFP	NNP	I-NP
suspended	suspended	VBD	0
in	in	IN	0
phosphate-buffered	phosphate-buffered	JJ	B-NP
saline	saline	NN	I-NP
(	(	-LRB-	0
0.25	0.25	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
was	was	VBD	0
microinjected	microinjected	VBN	0
into	into	IN	0
the	the	DT	0
nuclei	nuclei	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
Typically	Typically	RB	0
,	,	,	0
150-200	150-200	CD	0
cells	cells	NNS	0
were	were	VBD	0
injected	injected	VBN	0
for	for	IN	0
each	each	DT	0
condition	condition	NN	0
.	.	.	0
After	After	IN	0
microinjection	microinjection	VBG	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
incubated	incubated	VBN	0
in	in	IN	0
medium	medium	NN	0
containing	containing	VBG	0
10	10	CD	0
%	%	NN	0
fetal	fetal	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
for	for	IN	0
6	6	CD	0
hours	hours	NNS	0
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
washed	washed	VBN	0
several	several	JJ	0
times	times	NNS	0
with	with	IN	0
serum-free	serum-free	JJ	B-NP
medium	medium	JJ	I-NP
and	and	CC	0
placed	placed	VBN	0
in	in	IN	0
serum	serum	JJ	B-NP
deficient	deficient	JJ	0
media	media	NNS	0
for	for	IN	0
14	14	CD	0
hours	hours	NNS	0
to	to	TO	0
prevent	prevent	VB	0
GFP-GR	GFP-GR	JJ	B-NP
translocation	translocation	NN	I-NP
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
prior	prior	RB	0
to	to	TO	0
treatment	treatment	NN	0
with	with	IN	0
500	500	CD	0
nM	nM	JJ	B-NP
dexamethasona	dexamethasona	NN	I-NP
(	(	-LRB-	0
30	30	CD	0
min.	min.	CD	B-NP
)	)	-RRB-	0
or	or	CC	0
with	with	IN	0
vehicle	vehicle	NN	B-NP
alone	alone	RB	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
fixed	fixed	VBN	B-NP
by	by	IN	0
incubation	incubation	NN	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
supplemented	supplemented	NN	0
with	with	IN	0
4	4	CD	0
%	%	NN	0
paraformaldehyde	paraformaldehyde	NN	B-NP
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
and	and	CC	0
washed	washed	VBD	0
again	again	RB	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
before	before	IN	0
mounting	mounting	VBG	0
on	on	IN	0
slides	slides	NNS	0
with	with	IN	0
mounting	mounting	VBG	B-NP
solution	solution	NN	I-NP
dabco/dapi	dabco/dapi	NN	I-NP
.	.	.	0
GR-GFP	GR-GFP	JJ	B-NP
expression	expression	NN	I-NP
and	and	CC	0
localization	localization	NN	B-NP
were	were	VBD	0
monitored	monitored	VBN	0
by	by	IN	0
fluorescence	fluorescence	JJ	0
microscopy	microscopy	NN	0
.	.	.	0
Nuclei	Nuclei	NNP	0
were	were	VBD	0
localized	localized	VBN	0
by	by	IN	0
DAPI	DAPI	NNP	B-NP
staining	staining	NN	I-NP
.	.	.	0
Images	Images	NNS	0
were	were	VBD	0
captured	captured	VBN	0
with	with	IN	0
an	an	DT	0
optronic	optronic	NN	B-NP
cooled	cooled	VBD	0
CCD	CCD	NNP	0
camera	camera	NN	0
and	and	CC	0
imported	imported	VBN	0
into	into	IN	0
Adobe	Adobe	NNP	B-NP
Photoshop	Photoshop	NNP	I-NP
.	.	.	0
The	The	DT	0
experiments	experiments	NNS	0
were	were	VBD	0
repeated	repeated	VBN	0
4	4	CD	0
times	times	NNS	0
(	(	-LRB-	0
6	6	CD	0
for	for	IN	0
control	control	NN	0
)	)	-RRB-	0
.	.	.	0
One-way	One-way	JJ	B-NP
ANOVA	ANOVA	NNP	I-NP
was	was	VBD	0
performed	performed	VBN	0
to	to	TO	0
determine	determine	VB	0
statistical	statistical	JJ	B-NP
significance	significance	NN	I-NP
of	of	IN	0
the	the	DT	0
results	results	NNS	0
using	using	VBG	0
Instat	Instat	NNP	B-NP
2.03	2.03	NNP	0
(	(	-LRB-	0
GraphPad	GraphPad	NNP	B-NP
Software	Software	NNP	I-NP
,	,	,	0
San	San	NNP	0
Diego	Diego	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
GFP-NFAT	GFP-NFAT	JJ	B-NP
nuclear	nuclear	JJ	0
shuttling	shuttling	FW	0
assay	assay	FW	0
Stably-transfected	Stably-transfected	FW	0
HeLa	HeLa	NN	B-NP
cells	cells	FW	0
expressing	expressing	VBG	B-NP
GFP-NFAT	GFP-NFAT	NN	I-NP
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
were	were	VBD	0
grown	grown	VBN	0
on	on	IN	0
glass	glass	NN	B-NP
coverslip	coverslip	NN	I-NP
to	to	TO	0
approximately	approximately	RB	0
30	30	CD	0
%	%	NN	0
confluency	confluency	NN	B-NP
and	and	CC	0
either	either	RB	0
left	left	VBN	0
untreated	untreated	NNS	0
or	or	CC	0
treated	treated	VBN	0
with	with	IN	0
,	,	,	0
isi	isi	NN	B-NP
15534	15534	CD	0
,	,	,	0
or	or	CC	0
isi	isi	NN	B-NP
15521	15521	CD	0
(	(	-LRB-	0
a	a	DT	0
isi	isi	NN	B-NP
mismatched	mismatched	JJ	I-NP
oligonucleotide	oligonucleotide	JJ	I-NP
control	control	NN	I-NP
15534	15534	CD	0
)	)	-RRB-	0
in	in	IN	0
the	the	DT	0
serum	serum	VBG	B-NP
absence	absence	NN	I-NP
as	as	RB	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
Four	Four	CD	0
hours	hours	NNS	0
later	later	RB	0
,	,	,	0
fetal	fetal	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
10	10	CD	0
%	%	NN	0
and	and	CC	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
grown	grown	VBN	0
for	for	IN	0
an	an	DT	0
additional	additional	JJ	0
24	24	CD	0
hours	hours	NNS	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
treated	treated	VBN	0
with	with	IN	0
1	1	CD	0
μM	μM	JJ	B-NP
ionomycin	ionomycin	NN	I-NP
for	for	IN	0
30	30	CD	0
minutes	minutes	NNS	0
,	,	,	0
after	after	IN	0
which	which	WDT	0
time	time	NN	0
they	they	PRP	0
were	were	VBD	0
either	either	RB	0
fixed	fixed	VBN	B-NP
immediately	immediately	RB	0
or	or	CC	0
washed	washed	JJ	0
extensively	extensively	NN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
and	and	CC	0
incubated	incubated	NN	0
for	for	IN	0
6	6	CD	0
hours	hours	NNS	0
in	in	IN	0
medium	medium	NN	0
lacking	lacking	VBG	0
the	the	DT	0
drug	drug	NN	0
(	(	-LRB-	0
"washout	"washout	NNP	0
"	"	''	0
)	)	-RRB-	0
.	.	.	0
control	control	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
not	not	RB	0
incubated	incubated	VBN	0
with	with	IN	0
ionomycin	ionomycin	NN	B-NP
.	.	.	0
GFP-NFAT	GFP-NFAT	JJ	B-NP
localization	localization	NN	I-NP
was	was	VBD	0
monitored	monitored	VBN	0
by	by	IN	0
fluorescence	fluorescence	JJ	0
microscopy	microscopy	NN	0
,	,	,	0
and	and	CC	0
images	images	NNS	0
were	were	VBD	0
captured	captured	VBN	0
with	with	IN	0
an	an	DT	0
optronic	optronic	NN	B-NP
cooled	cooled	VBD	0
CCD	CCD	NNP	0
camera	camera	NN	0
and	and	CC	0
imported	imported	VBN	0
into	into	IN	0
Adobe	Adobe	NNP	B-NP
Photoshop	Photoshop	NNP	I-NP
.	.	.	0
